Category: GlobeNewswire

  • MIL-OSI: NextNRG Reports Preliminary May 2025 Revenue Growth of 148% Year-Over-Year

    Source: GlobeNewswire (MIL-OSI)

    AI-driven Energy Pioneer Delivers Best Month in Company History

    YTD Revenue Surpasses Total Revenue for All of 2024

    MIAMI, June 24, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (Nasdaq: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered through its Next Utility Operating System®, smart microgrids, wireless EV charging, and mobile fuel delivery, today announced preliminary unaudited financial results for May 2025.

    May 2025 Highlights:

    • Revenue: $6.6 million, up 148% year-over-year
    • Year-to-date revenue through May reached approximately $28.89 million, surpassing full-year 2024 revenue of approximately $27 million

    “We’re proud to report another month of strong revenue growth,” said Michael D. Farkas, Executive Chairman and CEO of NextNRG. “This marks our fifth consecutive record month, driven by the expansion of our operations and rising demand from partners nationwide. It reflects our continued operational momentum and the scalability of our model as we enter new markets. Crossing our full-year 2024 revenue total before mid-year is a clear indication that our execution strategy is working.

    NextNRG’s revenues continue to grow in scale, with strong adoption from commercial fleets and an expanding network of strategic partnerships. The company is also preparing to deploy its Next Utility Operating System®, AI-powered microgrid systems, and wireless EV charging products in key markets.

    Note on Preliminary Results
    The financial results for May 2025 are preliminary and unaudited. Final results may differ and will be confirmed upon the completion of standard month-end closing procedures.

    About NextNRG, Inc.
    NextNRG Inc. (NextNRG) is Powering What’s Next by implementing artificial intelligence (AI) and machine learning (ML) into renewable energy, next-generation energy infrastructure, battery storage, wireless electric vehicle (EV) charging and on-demand mobile fuel delivery to create an integrated ecosystem.

    At the core of NextNRG’s strategy is its Next Utility Operating System®, which leverages AI and ML to help make existing utilities’ energy management as efficient as possible, and the deployment of NextNRG smart microgrids, which utilize AI-driven energy management alongside solar power and battery storage to enhance energy efficiency, reduce costs and improve grid resiliency. These microgrids are designed to serve commercial properties, healthcare campuses, universities, parking garages, rural and tribal lands, recreational facilities and government properties, expanding energy accessibility while supporting decarbonization initiatives.

    NextNRG continues to expand its growing fleet of fuel delivery trucks and national footprint, including the acquisition of Yoshi Mobility’s fuel division and Shell Oil’s trucks, further solidifying its position as a leader in the on-demand fueling industry. NextNRG is also integrating sustainable energy solutions into its mobile fueling operations. The company hopes to be an integral part of assisting its fleet customers in their transition to EV, providing fuel delivery while advancing efficient energy adoption. The transition process is expected to include the deployment of NextNRG’s innovative wireless EV charging solutions.

    To find out more, visit: www.nextnrg.com.

    Forward-Looking Statements
    This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement describing NextNRG’s goals, expectations, financial or other projections, intentions, or beliefs is a forward-looking statement and should be considered an at-risk statement. Words such as “expect,” “intends,” “will,” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including, but not limited to, those related to NextNRG’s business and macroeconomic and geopolitical events. These and other risks are described in NextNRG’s filings with the Securities and Exchange Commission from time to time. NextNRG’s forward-looking statements involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although NextNRG’s forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by NextNRG. Except as required by law, NextNRG undertakes no obligation to update any forward-looking statements for any reason. As a result, you are cautioned not to rely on these forward-looking statements.

    Investor Relations Contact
    NextNRG, Inc.
    Sharon Cohen
    SCohen@nextnrg.com

    The MIL Network

  • MIL-OSI: Report Reveals Candidates’ Perspectives on Using AI in the Hiring Process

    Source: GlobeNewswire (MIL-OSI)

    DENVER, June 24, 2025 (GLOBE NEWSWIRE) — In today’s high-pressure hiring environment, where talent teams are expected to do more with less, Employ Inc. remains committed to delivering innovative, intelligent hiring solutions that meet the real-world needs of recruiters and talent acquisition leaders. Employ’s 2025 Job Seeker Nation Report reveals new data that underscores the growing complexity of the job search experience and what it means for hiring teams striving to keep up – especially as AI continues to reshape the hiring landscape. Based on responses from more than 1,500 job seekers, the report finds that 31 percent have used AI to support their job search in 2025, a seven-point increase from last year alone.

    This surge in AI usage is notably pronounced among desk-based professionals in industries like software, finance and government, where high application volumes and fierce competition are the norm. These job seekers are leveraging AI to streamline their own experiences from discovering relevant roles and crafting standout cover letters to analyzing their interview performance, raising the bar for employers, and amplifying the urgency for TA teams to adopt smarter, more adaptive tools.

    Job seekers are feeling the pressure from the competitive job market, and they’re responding by upskilling, especially in AI. Candidates are leaning in, not backing down, and that shift has real implications for talent acquisition teams. The report highlights that 66 percent of respondents reported feeling burned out from job searching, particularly in marketing, healthcare and food service roles. Most of these workers are investing in new skillsets, including AI literacy, to remain competitive.

    Meanwhile, TA teams are also leveraging AI, but not always in the ways candidates expect. While many job seekers are comfortable with AI being used to screen resumes, fewer use AI for resume creation themselves, revealing a gap in how each side engages with technology. This points to evolving comfort levels and expectations around technology’s role in hiring. Tools like Employ’s AI Interview Companion are helping recruiters streamline interviews, reduce bias, and create fairer experiences—benefits that resonate with candidates: 61 percent believe AI has the potential to make hiring more equitable.

    “As AI becomes more deeply embedded in both the candidate and recruiter experience, it’s essential that we use it to enhance—not replace—human connection,” said Stephanie Manzelli, Chief People Officer at Employ. “Candidates today are not just applying for jobs—they’re actively investing in their skills and seeking employers who do the same. That’s an opportunity for companies to differentiate through transparency, development, and trust.”

    Despite growing AI adoption on both sides of the hiring table, one truth remains: human connection matters most. The majority of job seekers (58 percent) still trust HR professionals more than algorithms when navigating the hiring process.

    Key Findings:

    • 1 in 3 job seekers used AI in their job search in 2025, up 7 points from 2024
    • Desk-based candidates in tech and finance are the highest AI adopters
    • 66 percent of job seekers report burnout, fueling interest in upskilling
    • 61 percent believe AI in hiring can reduce bias – but 58 percent still trust humans over machines

    To explore more candidate insights and actionable takeaways for recruiters, download the full 2025 Job Seeker Nation Report here.

    About Employ Inc.
    Employ delivers people-first intelligent hiring solutions that empower companies to overcome their greatest hiring challenges. From startups to Fortune 100 organizations, Employ meets companies where they are—offering tailored solutions that support everything from foundational hiring to advanced talent acquisition strategies. Employ is the only organization to offer companies choice in their hiring technology, providing three unique ATS platforms (JazzHR, Lever, and Jobvite) and AI Companions that work alongside you in your hiring journey. Our intelligent hiring suite is trusted by more than 23,000 customers, including e.l.f. Beauty, Pure Barre, Shutterfly, and Spotify. For more information, visit www.employinc.com.

    The MIL Network

  • MIL-OSI: CURRENC and Galaxy Payroll Group Partner to Develop AI-Powered HR Solutions

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced that it has entered a strategic partnership with Galaxy Payroll Group Limited (Nasdaq: GLXG) (“Galaxy Group”) to jointly create innovative AI-powered human resources solutions for CURRENC’s “AI Staff for Hire” platform. Leveraging Galaxy Group’s deep industry expertise and CURRENC’s advanced AI technology, the parties will develop two new modules, AI HR Manager and AI Recruitment Manager, extending CURRENC’s reach to the HR sector.

    CURRENC’s “AI Staff for Hire” platform empowers businesses across the financial industry to automate core functions, reduce operational costs, and make data-driven decisions. Its AI HR Manager module will be customized to streamline internal HR operations, from employee onboarding and performance monitoring to data management and reporting. Meanwhile, the AI Recruitment Manager will optimize the recruitment process, delivering intelligent candidate screening and automated interview scheduling to enhance hiring efficiency. Like all “AI Staff for Hire” solutions, these new HR modules will integrate smoothly into businesses’ existing workflows, enabling rapid implementation and adoption.

    “Collaborating with human resources leader Galaxy Group marks another milestone in our mission to transform business operations across the financial industry with AI-powered solutions,” said Alex Kong, Founder and Executive Chairman of CURRENC. “This partnership highlights how our ‘AI Staff for Hire’ platform can be seamlessly adapted to help clients in diverse financial sectors scale efficiently, reduce costs, and deliver superior customer experiences, demonstrating CURRENC’s leadership in AI innovation. Looking ahead, the Company is poised to build on this success, exploring additional AI-driven opportunities to facilitate digitalization and drive sustainable growth across industries.” 

    About CURRENC Group Inc.
    CURRENC Group Inc. (Nasdaq: CURR) is a fintech pioneer dedicated to transforming global financial services through artificial intelligence (AI). The Company empowers financial institutions worldwide with comprehensive AI solutions, including SEAMLESS AI Call Centre and other AI-powered Agents designed to reduce costs, increase efficiency and boost customer satisfaction for banks, insurance, telecommunications companies, government agencies and other financial institutions. The Company’s digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 global payment services, advancing financial access across underserved communities.

    Safe Harbor Statement
    This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties, or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

    Investor & Media Contact
    CURRENC Group Investor Relations
    Email: investors@currencgroup.com

    The MIL Network

  • MIL-OSI: CURRENC and Galaxy Payroll Group Partner to Develop AI-Powered HR Solutions

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced that it has entered a strategic partnership with Galaxy Payroll Group Limited (Nasdaq: GLXG) (“Galaxy Group”) to jointly create innovative AI-powered human resources solutions for CURRENC’s “AI Staff for Hire” platform. Leveraging Galaxy Group’s deep industry expertise and CURRENC’s advanced AI technology, the parties will develop two new modules, AI HR Manager and AI Recruitment Manager, extending CURRENC’s reach to the HR sector.

    CURRENC’s “AI Staff for Hire” platform empowers businesses across the financial industry to automate core functions, reduce operational costs, and make data-driven decisions. Its AI HR Manager module will be customized to streamline internal HR operations, from employee onboarding and performance monitoring to data management and reporting. Meanwhile, the AI Recruitment Manager will optimize the recruitment process, delivering intelligent candidate screening and automated interview scheduling to enhance hiring efficiency. Like all “AI Staff for Hire” solutions, these new HR modules will integrate smoothly into businesses’ existing workflows, enabling rapid implementation and adoption.

    “Collaborating with human resources leader Galaxy Group marks another milestone in our mission to transform business operations across the financial industry with AI-powered solutions,” said Alex Kong, Founder and Executive Chairman of CURRENC. “This partnership highlights how our ‘AI Staff for Hire’ platform can be seamlessly adapted to help clients in diverse financial sectors scale efficiently, reduce costs, and deliver superior customer experiences, demonstrating CURRENC’s leadership in AI innovation. Looking ahead, the Company is poised to build on this success, exploring additional AI-driven opportunities to facilitate digitalization and drive sustainable growth across industries.” 

    About CURRENC Group Inc.
    CURRENC Group Inc. (Nasdaq: CURR) is a fintech pioneer dedicated to transforming global financial services through artificial intelligence (AI). The Company empowers financial institutions worldwide with comprehensive AI solutions, including SEAMLESS AI Call Centre and other AI-powered Agents designed to reduce costs, increase efficiency and boost customer satisfaction for banks, insurance, telecommunications companies, government agencies and other financial institutions. The Company’s digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 global payment services, advancing financial access across underserved communities.

    Safe Harbor Statement
    This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties, or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

    Investor & Media Contact
    CURRENC Group Investor Relations
    Email: investors@currencgroup.com

    The MIL Network

  • MIL-OSI: Volta Finance Limited – Net Asset Value(s) as at 31 May 2025

    Source: GlobeNewswire (MIL-OSI)

    Volta Finance Limited (VTA / VTAS)
    May 2025 monthly report

    NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES

    Guernsey, June 24, 2025

    AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for May 2025. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com).

    Performance and Portfolio Activity

    Dear Investors,

    In May, Volta Finance’s net performance reached +3.3% bringing the performance from August 2024 to date to +10.7%. Our investments in CLO Debt and CLO Equity recovered some of their post-liberation day volatility due to improved market sentiment.

    May saw a more positive macroeconomic environment, helping markets recover most of the losses from the previous month. The 90-day tariff rollback from Washington towards China signaled a pause in the U.S. Both European and US Equity markets rose sharply, while credit indices showed a V-shaped recovery. U.S. 30-year Treasury yields rose above 5% for the first time since October 2023 after Moody’s downgraded the U.S. credit rating. Although yields fell back later in the month, this jump reminded investors of ongoing worries about fiscal health.

    In terms of macroeconomic data, US inflation was encouraging as CPIs cooled to 2.3 % year-on-year while the euro-area inflation held at 2.2 %. Impacted by tariffs, the U.S. Q1 GDP contracted by an annualized 0.3 % due to pre-tariff stockpiling, while the Eurozone experienced growth of +0.3% quarter-on-quarter, supported by resilient demand in the Services industry. Labor markets also showed positive figures on both sides of the Atlantic, with the euro-area unemployment rate reaching a record-low of 6.2 % notably.

    Credit markets performed strongly in May. The European High Yield index (Xover) was around 50bps tighter and closed 300bps. On the Loan side, Euro Loans closed almost 1pt up at 97.80px (Morningstar European Leveraged Loan Index) while US Loans closed c. 1 pt up at 96.70px. The primary CLO markets were active again, with levels tightening across the capital structure, notably with BBs in the Mid +500bps. In terms of performance, US BBs total returned +3% on the month. For comparison, US High Yield returned +1.7% in the same period while Euro High Yield was down +1.3% and Global Loans up +1.5%.

    In terms of loan fundamentals, default rates remained steady at 4.4% in the US (including Liability Management Exercises) but we noticed an uptick in downgrades with 12% of B- exposures downgraded down to CCC category by S&P in the US loan market.

    Due to ongoing uncertainties, we consciously decided not to fully reinvest our 16% cash position at the end of April. We ended May with c.10% of Volta’s NAV in cash, with capital deployment into €10.7m of CLO debt tranches as well as into our 2 warehouses. Our European CLO warehouse was converted into an effective CLO Equity at the end of the month. In addition, Volta Finance’s cashflow generation remained stable at €28.1m equivalent in interests and coupons over the last six months, representing close to 21% of May’s NAV on an annualized basis.

    Over the month, Volta’s CLO Equity tranches returned +5.9%** while CLO Debt tranches returned +2.8% performance**. The dollar slipped to a six-week low against the Euro at $1.15 per Euro with very limited impact of our long dollar exposure in terms of performance (-0.02%). In this uncertain macroeconomic environment, we have kept our net long USD exposure at c.13% to limit the potential for margin calls.

    As of end of May 2025, Volta’s NAV was €271.8m, i.e. €7.43 per share.

    *It should be noted that approximately 0.24% of Volta’s GAV comprises investments for which the relevant NAVs as at the month-end date are normally available only after Volta’s NAV has already been published. Volta’s policy is to publish its NAV on as timely a basis as possible to provide shareholders with Volta’s appropriately up-to-date NAV information. Consequently, such investments are valued using the most recently available NAV for each fund or quoted price for such subordinated notes. The most recently available fund NAV or quoted price was 0.17% as at 30 April 2025, 0.07% as at 31 March 2025.

    ** “performances” of asset classes are calculated as the Dietz-performance of the assets in each bucket, taking into account the Mark-to-Market of the assets at period ends, payments received from the assets over the period, and ignoring changes in cross-currency rates. Nevertheless, some residual currency effects could impact the aggregate value of the portfolio when aggregating each bucket.

    CONTACTS

    For the Investment Manager
    AXA Investment Managers Paris
    François Touati
    francois.touati@axa-im.com        
    +33 (0) 1 44 45 80 22

    Olivier Pons
    Olivier.pons@axa-im.com
    +33 (0) 1 44 45 87 30        

    Company Secretary and Administrator
    BNP Paribas S.A, Guernsey Branch
    guernsey.bp2s.volta.cosec@bnpparibas.com 
    +44 (0) 1481 750 853

    Corporate Broker
    Cavendish Securities plc
    Andrew Worne
    Daniel Balabanoff
    +44 (0) 20 7397 8900

    *****
    ABOUT VOLTA FINANCE LIMITED

    Volta Finance Limited is incorporated in Guernsey under The Companies (Guernsey) Law, 2008 (as amended) and listed on Euronext Amsterdam and the London Stock Exchange’s Main Market for listed securities. Volta’s home member state for the purposes of the EU Transparency Directive is the Netherlands. As such, Volta is subject to regulation and supervision by the AFM, being the regulator for financial markets in the Netherlands.

    Volta’s Investment objectives are to preserve its capital across the credit cycle and to provide a stable stream of income to its Shareholders through dividends that it expects to distribute on a quarterly basis. The Company currently seeks to achieve its investment objectives by pursuing exposure predominantly to CLO’s and similar asset classes. A more diversified investment strategy across structured finance assets may be pursued opportunistically. The Company has appointed AXA Investment Managers Paris an investment management company with a division specialised in structured credit, for the investment management of all its assets.

    *****

    ABOUT AXA INVESTMENT MANAGERS
    AXA Investment Managers (AXA IM) is a multi-expert asset management company within the AXA Group, a global leader in financial protection and wealth management. AXA IM is one of the largest European-based asset managers with 2,800 professionals and €859 billion in assets under management as of the end of June 2024.  

    *****

    This press release is published by AXA Investment Managers Paris (“AXA IM”), in its capacity as alternative investment fund manager (within the meaning of Directive 2011/61/EU, the “AIFM Directive”) of Volta Finance Limited (the “Volta Finance”) whose portfolio is managed by AXA IM.

    This press release is for information only and does not constitute an invitation or inducement to acquire shares in Volta Finance. Its circulation may be prohibited in certain jurisdictions and no recipient may circulate copies of this document in breach of such limitations or restrictions. This document is not an offer for sale of the securities referred to herein in the United States or to persons who are “U.S. persons” for purposes of Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or otherwise in circumstances where such offer would be restricted by applicable law. Such securities may not be sold in the United States absent registration or an exemption from registration from the Securities Act. Volta Finance does not intend to register any portion of the offer of such securities in the United States or to conduct a public offering of such securities in the United States.

    *****

    This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The securities referred to herein are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Past performance cannot be relied on as a guide to future performance.

    *****
    This press release contains statements that are, or may deemed to be, “forward-looking statements”. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes”, “anticipated”, “expects”, “intends”, “is/are expected”, “may”, “will” or “should”. They include the statements regarding the level of the dividend, the current market context and its impact on the long-term return of Volta Finance’s investments. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Volta Finance’s actual results, portfolio composition and performance may differ materially from the impression created by the forward-looking statements. AXA IM does not undertake any obligation to publicly update or revise forward-looking statements.

    Any target information is based on certain assumptions as to future events which may not prove to be realised. Due to the uncertainty surrounding these future events, the targets are not intended to be and should not be regarded as profits or earnings or any other type of forecasts. There can be no assurance that any of these targets will be achieved. In addition, no assurance can be given that the investment objective will be achieved.

    The figures provided that relate to past months or years and past performance cannot be relied on as a guide to future performance or construed as a reliable indicator as to future performance. Throughout this review, the citation of specific trades or strategies is intended to illustrate some of the investment methodologies and philosophies of Volta Finance, as implemented by AXA IM. The historical success or AXA IM’s belief in the future success, of any of these trades or strategies is not indicative of, and has no bearing on, future results.

    The valuation of financial assets can vary significantly from the prices that the AXA IM could obtain if it sought to liquidate the positions on behalf of the Volta Finance due to market conditions and general economic environment. Such valuations do not constitute a fairness or similar opinion and should not be regarded as such.

    Editor: AXA INVESTMENT MANAGERS PARIS, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6, Place de la Pyramide – 92800 Puteaux. AXA IMP is authorized by the Autorité des Marchés Financiers under registration number GP92008 as an alternative investment fund manager within the meaning of the AIFM Directive.

    *****

    Attachment

    The MIL Network

  • MIL-OSI: POET Signs Manufacturing Agreement with NationGate Solutions in Malaysia

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Corporation”) (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced that it has signed a Master Agreement, Module Purchase Agreement and a Deed of Consignment with NationGate Solutions (M) Sdn. Bhd (“NationGate”), to manufacture optical engine assemblies for POET in Penang, Malaysia.

    POET has engaged with NationGate to assemble and test consigned optical engines with a custom-designed fiber-attach unit (FAU) made specifically for one of POET’s key customers. That customer has confirmed a high level of interest from hyperscale data centers in a product that includes a combination of optical engines available exclusively from POET.

    “We are thrilled to be engaged with POET, whose profile in Malaysia is increasingly prominent,” said Dato Ooi Eng Leong, CEO of NationGate Solutions (M) Sdn. Bhd., the largest electronics manufacturing services provider in Malaysia. “We share POET’s enthusiasm about a Malaysia-centered ecosystem for the manufacturing of advanced optoelectronics products to complement what we are already manufacturing for some of the largest AI network systems providers in the world.”

    “The level of dedication to a shared mission that we see from our partners has far exceeded our expectations and confirms that our decision to focus manufacturing of Optical Interposer-based products in Malaysia was the best path for POET,” said Dr. Suresh Venkatesan, Chairman & CEO of POET Technologies Inc. “Through the relationships, talent and world-class facilities offered by our partners, POET is able to demonstrate the ability to scale manufacturing to the volumes demanded by our customers, bringing us that much closer to significant revenue generation in the near future.”

    Update on Sample Shipments
    The agreement with NationGate is in addition to the Company’s manufacturing agreement with Globetronics, which was announced in December of 2024. The Company confirmed that its operation in Globetronics had progressed to the point that it had, as of early June, shipped its order backlog of sample 800G optical engines to existing customers. The Company expects to ship its backlog of 1.6T samples during Q3 of 2025.

    Both the Globetronics and NationGate facilities have initiated critical qualification processes. Once fully on-line, these facilities will ensure continuity and scalability in delivering POET’s high performance photonics solutions to global customers. Establishing a Malaysian manufacturing footprint is in direct response to increasing customer demand and the strategic need for POET to diversify and secure the Company’s supply chain. POET’s Optical Interposer-based Optical Engines and other assemblies are directed at applications in data centers, AI, high performance computing and telecom networks.

    About POET Technologies Inc.
    POET is a design and development company offering high-speed optical modules, optical engines and light source products to the artificial intelligence systems market and to hyperscale data centers. POET’s photonic integration solutions are based on the POET Optical Interposer™, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using advanced wafer-level semiconductor manufacturing techniques. POET’s Optical Interposer-based products are lower cost, consume less power than comparable products, are smaller in size and are readily scalable to high production volumes. In addition to providing high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale data centers, POET has designed and produced novel light source products for chip-to-chip data communication within and between AI servers, the next frontier for solving bandwidth and latency problems in AI systems. POET’s Optical Interposer platform also solves device integration challenges in 5G networks, machine-to-machine communication, self-contained “Edge” computing applications and sensing applications, such as LIDAR systems for autonomous vehicles. POET is headquartered in Toronto, Canada, with operations in, Shenzhen, China, Penang, Malaysia and Singapore. More information about POET is available on our website at www.poet-technologies.com.

    About NationGate Holdings Sdn. Bhd. (0270.KL)
    NationGate is Malaysia’s leading Electronics Manufacturing Services (EMS) Provider. Since its inception before 2010, NationGate has been providing electronics manufacturing services and technical support to (IoT) Internet of Things, Consumer electronics , Industrial Instrumentation, Data computing , Networking, Telecommunications , Medical , Automotive, Artificial Intelligence (AI) Equipment and Aerospace sectors. Our vision is to serve the various industrial sectors by providing the best alternative of choice to potential prospectus. Services provided by NationGate include complex and high speed SMT (Surface Mount Technology), COB (Chip On Flex/ Board), Final Assembly (Box Build), precision Plastic Moulding, Final Testing services and Advanced Laboratory Services.

    Forward-Looking Statements
    This news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Corporation’s expectations with respect to its business partnership with NationGate, success of the Corporation’s product development efforts, the performance of its products, operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Corporation’s technology as well as the market acceptance, inclusion and timing of the Corporation’s technology in current and future products and expectations regarding its successful penetration of the Artificial Intelligence hardware markets.

    Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, its expectations for the partnership with NationGate, the negotiations with contract manufacturers, the size, future growth and needs of Artificial Intelligence network suppliers, management’s expectations regarding the success and timing for completion of its development efforts, the introduction of new products, financing activities, future growth, recruitment of personnel, reorganization efforts, plans for and completion of projects by the Corporation’s consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, failure to receive necessary regulatory approvals for the Corporation’s arrangements with NationGate and Globetronics, the failure of Artificial Intelligence networks to continue to grow as expected, the failure of the Corporation’s products to meet performance requirements for AI and datacom networks, lack of sales in its products, lack of sales by its customers to end-users, operational risks in the completion of the Corporation’s projects, risks affecting the Corporation’s ability to complete its products, the ability of the Corporation to generate sales for its products, the ability of its customers to generate sales for products that incorporate the Corporation’s products, the ability to attract key personnel, the failure of its reorganization efforts and the ability to raise additional capital when needed. Although the Corporation believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Corporation’s securities should not place undue reliance on forward-looking statements because the Corporation can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Corporation assumes no obligation to update or revise this forward-looking information and statements except as required by law.

    Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
    120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075

    The MIL Network

  • MIL-OSI: OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

    Source: GlobeNewswire (MIL-OSI)

    WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025.

    Mr. Silvestro joined the Company in 2019 and has been the Company’s CEO since March 2025, after serving as the interim CEO from January 2025. The appointment of Mr. Silvestro, with his knowledge of the Company and expertise in the industry, will enhance overall leadership and greatly contribute to the Company’s ability to execute its value creation plans and support key initiatives to deliver on its customer and shareholder roadmap.

    “The Board of Directors has been impressed with Steve’s leadership and the meaningful progress the Company has made since he stepped into the CEO role,” said Lynn Vos, Chairperson of OptimizeRx’s Board of Directors. “The initiatives he and the leadership team have executed have significantly strengthened OptimizeRx’s position with customers and laid a solid foundation for sustained long-term shareholder value creation. We’re pleased to welcome Steve to the Board and look forward to his continued contributions as we work together to refine and advance the Company’s strategic direction.”

    “It’s truly an honor to have the trust of such an experienced Board and be able to lead a team that is focused on operational excellence and customer delight,” added Steve Silvestro. “I am excited with the direction OptimizeRx is headed and believe we’re firmly positioned for a strong 2025 and are building a solid foundation for continued growth and execution in 2026 and beyond. I’m excited to join the Company’s Board and look forward to continuing to partner with our team, strategic partners, and customers as we continue to drive the Company’s growth. Our focus will remain on delivering exceptional customer experiences, deepening our value proposition with pharmaceutical partners, accelerating our shift toward a recurring revenue model, and progressing toward Rule of 40 performance.”

    About Stephen L. Silvestro

    Steve Silvestro was appointed Chief Executive Officer in March 2025. He joined the Company as Chief Commercial Officer in April 2019 and has since served as President from October 2023 until his appointment as interim CEO in January 2025. Prior to joining the Company, Mr. Silvestro was with CCH® Tagetik, a Wolters Kluwer company that provides corporate performance management software solutions for planning, consolidation and reporting, as its Vice President and General Manager from January 2018 until April 2019. From April 2017 to January 2018, Mr. Silvestro was with Prognos Health, Inc., a healthcare data and analytics company, as its Chief Commercial Officer and, before that, from September 2007 to April 2017, he was with Decision Resources Group, a multi-national corporation that provides high value global data solutions, analytics and consulting services to pharmaceutical, biotech, medical device, healthcare provider and payer, and managed care companies, in various capacities with him last serving as Executive Vice President, Head of Global Sales.

    About OptimizeRx

    OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

    Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.

    Important Cautions Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements in this press release that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to OptimizeRx’s commitment to appointing directors who have perspectives, insights, experiences, and skills that expand the depth and breadth of the Board, executing the Company’s value creation plans, supporting key initiatives, advancing the Company’s strategic direction, delivering exceptional customer experiences, deepening the Company’s value proposition with pharmaceutical partners, accelerating the Company’s shift towards a recurring revenue model, progressing towards a Rule of 40 performance, and other statements relating to future performance, plans, and expectations. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company’s current expectations and involve assumptions regarding the Company’s business, the economy, and other future conditions that may never materialize or may prove to be incorrect. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company’s ability to identify and appoint a new independent director, the effect of government regulation, seasonal trends, dependence on a concentrated group of customers, cybersecurity incidents that could disrupt operations, the ability to keep pace with growing and evolving technology, the ability to maintain contracts with electronic prescription platforms and electronic health records networks, competition, and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.

    OptimizeRx Contact 

    Andy D’Silva, SVP Corporate Finance   
    adsilva@optimizerx.com
      
    Investor Relations Contact
    Steven Halper
    LifeSci Advisors, LLC
    shalper@lifesciadvisors.com

    The MIL Network

  • MIL-OSI: Advanced Flower Capital Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025

    Source: GlobeNewswire (MIL-OSI)

    WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC”) today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 14th, 2025 before market open. Management will review AFC’s financial results at 10:00 am ET via webcast available on the Investor Relations section of AFC’s website found here AFC — Investor Relations. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event.

    AFC distributes its earnings releases via its website and email lists. Those interested in receiving firm updates by email can sign up for them here.

    About Advanced Flower Capital Inc.

    Advanced Flower Capital Inc. (Nasdaq: AFCG) is a leading commercial mortgage REIT that provides institutional loans to state law compliant cannabis operators in the U.S. Through the management team’s deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows. It is based in West Palm Beach, Florida. For additional information regarding AFC, please visit advancedflowercapital.com.

    Investor Relations Contact

    Robyn Tannenbaum
    561-510-2293
    ir@advancedflowercapital.com

    Media Contact

    Collected Strategies
    Jim Golden / Jack Kelleher
    AFCG-CS@collectedstrategies.com

    The MIL Network

  • MIL-OSI: Giga‑markets365 Launches Enhanced Learning Hub with 200+ New Courses & Webinars

    Source: GlobeNewswire (MIL-OSI)

    LONDON, June 24, 2025 (GLOBE NEWSWIRE) — Giga‑markets365.com has launched a significantly enhanced version of its educational platform, introducing over 200 new courses, webinars, and training resources aimed at supporting users in navigating global financial markets. The update marks a major milestone in the company’s mission to promote financial literacy and improve decision-making through accessible, self-paced learning tools.

    The upgraded Learning Hub features multilingual content, expert-led webinars, and real-time market analysis sessions designed to cater to both beginner and advanced users. With financial literacy becoming increasingly critical in a digitally driven economy, Giga‑markets365’s expanded content library offers practical education across asset classes including forex, crypto, stocks, indices, and commodities.

    In addition to its on-demand video lessons, the platform now hosts weekly live sessions with professional traders and analysts, offering users interactive opportunities to engage with market movements and trading strategies in real time. Early participation metrics have shown a marked increase in user engagement, with thousands attending the first wave of webinars following the soft launch earlier this month.

    “The goal of the enhanced Learning Hub is to bridge the knowledge gap for individuals entering the financial space,” said a company representative. “We’re seeing demand from both mature and emerging markets for resources that are not only comprehensive but tailored to everyday users.”

    This educational expansion complements the platform’s broader strategy of accessibility and operational consistency. Giga‑markets365.com is already recognized for its user-centric tools, simplified navigation, and multilingual support, which have contributed to its strong user retention and positive review metrics globally.

    The company’s infrastructure continues to reflect a commitment to usability and transparency. Its integration of educational tools within the trading interface enables users to apply insights directly, reinforcing retention and real-world comprehension. The Learning Hub’s launch is being rolled out in stages across different time zones, with additional localized content scheduled for release throughout Q3 2025.

    Security and data privacy remain key components of the platform’s digital ecosystem. The Learning Hub, like other services offered by Giga‑markets365, operates within encrypted environments and aligns with international compliance standards to protect user activity and data integrity.

    As part of its educational rollout, Giga‑markets365.com plans to host a series of regional virtual events and panel discussions later this year, further strengthening its commitment to public financial empowerment and industry knowledge exchange.

    About Giga-markets365.com

    Giga‑markets365 is a global financial services platform offering users direct access to a wide range of markets, including forex, stocks, indices, commodities, and cryptocurrencies. Built on a foundation of operational reliability, simplified user tools, and multilingual support, the platform is designed to meet the needs of both new and experienced traders. With a focus on transparency, accessibility, and continuous education, Giga‑markets365 provides an integrated trading environment supported by real-time market data, secure infrastructure, and responsive user service. The company continues to expand its presence in both established and emerging markets through strategic platform enhancements and educational outreach.

    Company Details

    Company Name: Giga-markets365
    Email Address: media@giga-markets365.com
    Company Address: 1 Clement’s Inn, London WC2A 2AZ, United kingdom.
    Company Website: https://giga-markets365.com

    Disclaimer: This press release is provided by Giga-markets365. The statements, views, and opinions expressed are solely those of the provider and do not necessarily reflect those of this media platform or its publisher. Any names or brands mentioned are used for identification purposes only and remain the property of their respective owners. No endorsement or guarantee is made regarding the accuracy, completeness, or reliability of the information presented. This material is for informational purposes only and does not constitute financial, legal, or professional advice. Readers are encouraged to conduct independent research and consult qualified professionals. The publisher is not liable for any losses, damages, or legal issues arising from the use or publication of this content.

    The MIL Network

  • MIL-OSI: Pando and JBF Consulting Release 2025 Report on the State of AI in Logistics

    Source: GlobeNewswire (MIL-OSI)

    CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) — Pando, a leading logistics AI company, and JBF Consulting, a leading logistics strategy advisory and technology integration firm, have released the inaugural edition of the State of AI in Logistics report. This new report provides in-depth insights into both the potential of AI as well as the challenges organizations face as they work to integrate it into their supply chain and logistics operations – beyond just a tool for incremental productivity improvements. While enthusiasm for AI is strong and investment continues to grow, most organizations are still in the early stages of adoption.

    Based on in-depth interviews with supply chain leaders across industries, the study reveals a critical inflection point in AI adoption, exposing the disconnect between AI ambitions and practical implementation realities. To provide continued visibility into these trends, Pando and JBF Consulting will publish the report annually to provide a clear benchmark on the progress and impact of AI adoption across supply chain and logistics operations.

    Key findings from the report include:

    • 54% of companies remain in value discovery stages with regard to AI adoption within their logistics function.
    • 91% have increased AI investments over the past 24 months, with 75% planning significant increases in the next two years.
    • 83% cite data quality as their most significant technical barrier.
    • 92% believe AI can help navigate ecosystem complexity in logistics.

    “Supply chains no longer operate on a nine-to-five schedule; they move in real time, where a single disruption can overturn a company’s entire operations overnight,” said Abhijeet Manohar, CTO and co-founder of Pando. “In such a volatile, uncertain, complex, and ambiguous world, AI adoption in supply chain and logistics is no longer optional; it’s foundational to resilience. This report highlights how global supply chain teams are using AI every day to drive high-impact decision-making. Conversations with leaders across the industry have validated that early adopters want to pilot fast, provide value in weeks, and scale without the drag of traditional change management. This shift toward ‘rapid time to value’ is accelerating AI’s transformation from an aspirational goal into a real-time decision engine powering global logistics.”

    “The logistics industry is at a pivotal moment, with next-generation AI set to fundamentally reshape how businesses operate and how people work,” said Mike Mulqueen, Executive Principal at JBF Consulting. “This report comes at a critical time, offering practical insights for industry leaders looking to integrate AI into their logistics strategies to stay ahead in a rapidly evolving environment. Successful AI implementation takes more than just integrating a new technology – it also depends on reliable data, clear objectives, and a willingness to change traditional processes. The organizations that approach AI as a strategic differentiator are poised to create a substantial competitive advantage.”

    According to the State of AI in Logistics 2025 report, 38% of large enterprises now run dedicated data-science teams that build bespoke logistics-AI solutions and collaborate with specialist AI-first vendors. The once binary build-vs-buy debate has therefore matured into a pragmatic hybrid model. History shows what follows. When desktop PCs replaced ledgers, clerks became spreadsheet power-users; when the internet and cloud arrived, on-prem admins morphed into remote work orchestrators. AI agents represent the same kind of tipping point. Rather than eliminating jobs, they redefine them – freeing people to tackle higher-order exceptions, strategy, and customer innovation.

    “What makes this moment different is the emergence of Agentic AI and AI systems that can operate autonomously within organizational guardrails, take proactive decisions, and collaborate with humans in real-time,” continued Manohar. “This is a significant leap from past AI applications that were largely behind the scenes in a support role. In the current supply chain climate, AI agents offer the kind of dynamic decision-making and adaptability that modern logistics demand.”

    Looking ahead, the study also reveals that several key developments will shape the logistics industry:

    • AI as a competitive edge: Organizations taking decisive action to implement AI solutions now, rather than waiting for ideal conditions, gain compounding advantages in data quality, institutional knowledge, and operational workflows.
    • Human AI collaboration: Rather than complete replacement, we expect to see a reconfiguration of human roles to focus on judgment, creativity, and relationship management, with AI handling routine decisions and processes.
    • AI adoption across ecosystems: Integration across the ecosystem will continue to intensify. AI capabilities will increasingly bridge organizational boundaries, enabling more seamless coordination across the fragmented logistics landscape.

    The logistics landscape has never been more dynamic or challenging to navigate. Global disruptions, volatile markets, and elevated customer expectations create a complex operating environment that tests even the most sophisticated organizations. AI’s role in logistics is evolving rapidly, and those who understand how to harness its power will be more resilient, agile, and gain a distinct competitive advantage in today’s complex global supply chain. The State of AI in Logistics report offers essential insights and practical guidance to help companies navigate the complexities of AI adoption at any point on their AI journey.

    Download the full 2025 State of AI in Logistics report to explore how AI can transform your supply chain and logistics operations at  https://pando.ai/resources/industry-reports/state-of-ai-in-logistics-2025?utm_campaign=8220719-2025%20AI%20Agents&utm_source=press-release-global-newswire

    About Pando
    Pando is a global leader in AI-powered logistics technology and offers AI Agents for logistics, enabling manufacturers, distributors, and retailers to automate their logistics operations to build agility, control freight spend, and reduce carbon footprint. Trusted by Fortune 500 enterprises across North America, Europe, and Asia Pacific regions, Pando is pioneering the future of Autonomous Logistics with its AI Agents. Pando is recognized by Gartner as a Visionary, by the World Economic Forum (WEF) as a Technology Pioneer, by G2 as a Market Leader in Freight Management, and named one of the fastest-growing technology companies by Deloitte. For more information, visit www.pando.ai.

    About JBF Consulting
    JBF Consulting is a leading logistics strategy advisory and technology integration firm that partners with shippers to transform their logistics and supply chain execution operations. We empower clients to achieve operational efficiency and scalable, sustainable value through strategy development, roadmap orchestration, unbiased technology selection, expert implementation, data-driven insights, and ongoing managed services. For over two decades, our client-centric approach and partnerships with best-of-breed solution providers have ensured that every strategy and solution we deliver drives measurable impact, long-term success, and customer satisfaction. For more information, visit www.jbf-consulting.com.

    Media Contacts
    Courtney Meints
    Skyya PR for Pando
    pando@skyya.com

    Caroline Proctor
    JBF Consulting
    Caroline.proctor@jbf-consulting.com
    240-401-5315

    The MIL Network

  • MIL-OSI: Lantronix Named the 2025 Industrial IoT Company of the Year by Leading Market Research Firm CompassIntel

    Source: GlobeNewswire (MIL-OSI)

    IRVINE, Calif., June 24, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that Lantronix has been named the 2025 Industrial IoT Company of the Year by CompassIntel, a leading market research and advisory firm specializing in metrics-driven market intelligence and insights for the mobile, IoT and high-tech industries.

    The 13th annual CompassIntel Awards honor companies, vendors and organizations that have demonstrated innovation, leadership, disruption and excellence in the mobile, IoT, business tech and emergency technology industries. Winners were chosen by a panel of industry-leading press, editors, journalists, thought leaders and analysts.

    “We are honored to receive the 2025 Industrial IoT Company of the Year Award from CompassIntel. At Lantronix, we are dedicated to driving innovation and accelerating our customers’ success by equipping them with cutting-edge IoT technologies and services that propel them into the future,” said Saleel Awsare, CEO and president of Lantronix Inc. “Our long-term partnership with Qualcomm and other key industry leaders allows us to create and deliver groundbreaking IoT solutions, enabling our customers to leverage the power of Edge AI Intelligence.”

    “As we celebrate the 13th Annual CompassIntel Awards, we honor the trailblazers and visionaries shaping the future of technology and innovation. These recipients, including Lantronix, represent the best in their fields, pushing boundaries and driving transformation across industries,” said Stephanie Atkinson, CEO & founder of Compass Intelligence.

    About Compass Intelligence

    Compass Intelligence is a market research and advisory firm specializing in metrics-driven market intelligence and insights for the mobile, IoT, and high-tech industries serving tech clients for more than 17 years. Compass Intelligence provides executive insights, market sizing/forecasting and modeling, competitive analysis, strategic consulting, advisory services, trending analysis, and survey research services. Compass Intelligence helps guide strategic business decisions and supports in the success of our clients through delivering content engagement, go to market planning, competitive positioning, and strategic advisory. For more information, please visit https://www.compassintel.com.

    About Lantronix

    Lantronix Inc. is a global leader of compute and connectivity IoT solutions that target high-growth markets, including Smart Cities, Enterprise and Transportation. Lantronix’s products and services empower companies to succeed in the growing IoT markets by delivering customizable solutions that enable AI Edge Intelligence. Lantronix’s advanced solutions include Intelligent Substations infrastructure, Infotainment systems and Video Surveillance, supplemented with advanced Out-of-Band Management (OOB) for Cloud and Edge Computing.

    For more information, visit the Lantronix website.

    ©2025 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

    “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking statements within the meaning of federal securities laws, including, without limitation, statements related to Lantronix products or leadership team. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition, or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; our ability to mitigate any disruption in our and our suppliers’ and vendors’ supply chains due to the COVID-19 pandemic or other outbreaks, wars and recent tensions in Europe, Asia and the Middle East, or other factors; future responses to and effects of public health crises; cybersecurity risks; changes in applicable U.S. and foreign government laws, regulations, and tariffs; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; the level of our indebtedness, our ability to service our indebtedness and the restrictions in our debt agreements; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission (the “SEC”) on Sept. 9, 2024, including in the section entitled “Risk Factors” in Item 1A of Part I of that report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. In addition, actual results may differ as a result of additional risks and uncertainties about which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of the Nasdaq Stock Market LLC. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.

    Lantronix Media Contact:        

    Gail Kathryn Miller
    Corporate Marketing &
    Communications Manager
    media@lantronix.com

    Lantronix Analyst and Investor Contact:        
    investors@lantronix.com

    The MIL Network

  • MIL-OSI: Red White & Bloom Brands Announces New Date for Annual General Meeting

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that its Annual General Meeting (“AGM”), originally scheduled for Friday, June 27, 2025, has been rescheduled to Friday, July 11, 2025. The change will allow for the completion and filing of the Company’s audited financial statements and accompanying management discussion and analysis for the year-ended December 31, 2024, both of which will be presented at the AGM. The change to the annual general meeting date is permissible in accordance with the record date established for the AGM.

    The AGM will be held at the same time and location as indicated in the proxy materials mailed to shareholders on May 28, 2025, which remain available on SEDAR+ at www.sedarplus.ca and on the Company’s website at: https://ir.redwhitebloom.com/news-events/ir-calendar.

    Voting remains open and shareholders may cast their votes until 8:00 am Pacific Time on Wednesday, July 9, 2025. The Company confirms that no new proxy materials will be issued in connection with the rescheduled AGM, and that the previously distributed proxy materials remain valid for use at the rescheduled meeting.

    About Red White & Bloom Brands Inc.

    Red White & Bloom Brands is a multi-jurisdictional cannabis operator and house of premium brands operating in the United States, Canada and internationally. The Company is predominantly focusing its investments on major U.S. markets, including California, Florida, Missouri, Michigan, and Ohio in addition to Canadian and international markets.

    Red White & Bloom Brands Inc.
    Investor and Media Relations
    Edoardo Mattei, CFO
    IR@RedWhiteBloom.com
    947-225-0503

    Visit us on the web: https://www.redwhitebloom.com/.

    Follow us on social media:

    Twitter @rwbbrands

    Facebook @redwhitebloombrands

    Instagram @redwhitebloombrands

    Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    FORWARD LOOKING INFORMATION

    Certain information contained in this news release may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking information is often identified by the use of words such as “plans,” “expects,” “may,” “should,” “could,” “will,” “intends,” “anticipates,” “believes,” “estimates,” “forecasts,” or variations of such words and phrases, including the negative forms thereof, as well as terms such as “pro forma” and “scheduled,” and similar expressions that refer to future events or outcomes.

    Forward-looking statements in this release include, without limitation, statements regarding the rescheduled date of the AGM, the anticipated completion and filing of the Company’s audited financial statements and accompanying management’s discussion and analysis, and the timing of shareholder voting.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, delays in the preparation or filing of financial statements; the ability to meet regulatory and stock exchange requirements; market conditions; and other risks relating to the Company’s business and financial condition.

    There can be no assurance that such forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

    The Company disclaims any obligation to update or revise any forward-looking information contained herein, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

    THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE COMPANY’S EXPECTATIONS AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

    The MIL Network

  • MIL-OSI: Red White & Bloom Brands Announces New Date for Annual General Meeting

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that its Annual General Meeting (“AGM”), originally scheduled for Friday, June 27, 2025, has been rescheduled to Friday, July 11, 2025. The change will allow for the completion and filing of the Company’s audited financial statements and accompanying management discussion and analysis for the year-ended December 31, 2024, both of which will be presented at the AGM. The change to the annual general meeting date is permissible in accordance with the record date established for the AGM.

    The AGM will be held at the same time and location as indicated in the proxy materials mailed to shareholders on May 28, 2025, which remain available on SEDAR+ at www.sedarplus.ca and on the Company’s website at: https://ir.redwhitebloom.com/news-events/ir-calendar.

    Voting remains open and shareholders may cast their votes until 8:00 am Pacific Time on Wednesday, July 9, 2025. The Company confirms that no new proxy materials will be issued in connection with the rescheduled AGM, and that the previously distributed proxy materials remain valid for use at the rescheduled meeting.

    About Red White & Bloom Brands Inc.

    Red White & Bloom Brands is a multi-jurisdictional cannabis operator and house of premium brands operating in the United States, Canada and internationally. The Company is predominantly focusing its investments on major U.S. markets, including California, Florida, Missouri, Michigan, and Ohio in addition to Canadian and international markets.

    Red White & Bloom Brands Inc.
    Investor and Media Relations
    Edoardo Mattei, CFO
    IR@RedWhiteBloom.com
    947-225-0503

    Visit us on the web: https://www.redwhitebloom.com/.

    Follow us on social media:

    Twitter @rwbbrands

    Facebook @redwhitebloombrands

    Instagram @redwhitebloombrands

    Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    FORWARD LOOKING INFORMATION

    Certain information contained in this news release may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking information is often identified by the use of words such as “plans,” “expects,” “may,” “should,” “could,” “will,” “intends,” “anticipates,” “believes,” “estimates,” “forecasts,” or variations of such words and phrases, including the negative forms thereof, as well as terms such as “pro forma” and “scheduled,” and similar expressions that refer to future events or outcomes.

    Forward-looking statements in this release include, without limitation, statements regarding the rescheduled date of the AGM, the anticipated completion and filing of the Company’s audited financial statements and accompanying management’s discussion and analysis, and the timing of shareholder voting.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, delays in the preparation or filing of financial statements; the ability to meet regulatory and stock exchange requirements; market conditions; and other risks relating to the Company’s business and financial condition.

    There can be no assurance that such forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

    The Company disclaims any obligation to update or revise any forward-looking information contained herein, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

    THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE COMPANY’S EXPECTATIONS AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

    The MIL Network

  • MIL-OSI: Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen the facility’s security and provide AI-powered weapon detection. Xtract One’s leading technology-driven threat detection and security solutions are designed to enhance safety for patients, visitors, and staff at the medical center, starting with the main campus with plans to later expand to all satellite clinics.

    This deployment comes at a critical time for healthcare facilities, following California’s recent Assembly Bill (AB) 2975. With hospitals now being required to implement weapons detection screening policies at key entrances as a minimum, San Mateo Medical Center demonstrates its forward-thinking and proactive stance in deploying Xtract One’s cutting-edge technology designed to help elevate safety while enhancing the overall individual experience.

    “With violent incidents being five times more frequent in healthcare facilities than in other industries, we recognize the unique challenge hospitals face in ensuring a safe environment,” said Peter Evans, CEO of Xtract One. “Our SmartGateway has shown proven efficacy in on-site, real-world testing and we are confident that its deployment at San Mateo Medical Center will provide enhanced security that identifies potential threats of all kinds, including firearms and edged weapons, and minimizes disruptions to patients, staff, and visitors. We’re looking forward to working with San Mateo Medical Center and to showcasing how well SmartGateway supports healthcare facilities’ needs.”

    “Our goal is to create a safe and welcoming environment for everyone who enters our facility so that we can focus on what truly matters–our patients’ well-being” said Robet Blake, COO of San Mateo Medical Center. “Deploying Xtract One’s technology at our main campus reinforces that commitment. After extensive testing of various systems, we found SmartGateway’s innovative technology to be the most effective for our facility’s needs, allowing us to stay ahead of potential threats in order to maintain a secure and welcoming campus for everyone.”

    SmartGateway’s breakthrough innovation provides fast, discreet, and reliable individual screening, utilizing AI-powered sensors that unobtrusively scan guests for weapons and other prohibited items as they walk through. This technology replaces traditional metal detectors, reducing the need to empty pockets, optimizing patron experience by reducing time spent in security lines, and providing critical security insights to maximize screening outcomes. SmartGateway is designed to enable seamless passage through checkpoints and promote uninterrupted flow of movement.

    To learn more, visit www.xtractone.com.

    About Xtract One
    Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

    About San Mateo Medical Center
    San Mateo Medical Center is a public hospital and clinic system fully accredited by The Joint Commission. We operate outpatient clinics throughout the county and an acute-care hospital in San Mateo. Our mission is to “partner with our community to provide excellent healthcare for patients, including those experiencing social, environmental, or economic challenges.” As part of San Mateo County Health, the medical center serves the healthcare needs of all residents of San Mateo County, with an emphasis on education and prevention.

    About Threat Detection and Security Solutions
    Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

    Forward Looking Statements
    This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

    For further information, please contact:
    Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com   
    Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
    Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

    The MIL Network

  • MIL-OSI: Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen the facility’s security and provide AI-powered weapon detection. Xtract One’s leading technology-driven threat detection and security solutions are designed to enhance safety for patients, visitors, and staff at the medical center, starting with the main campus with plans to later expand to all satellite clinics.

    This deployment comes at a critical time for healthcare facilities, following California’s recent Assembly Bill (AB) 2975. With hospitals now being required to implement weapons detection screening policies at key entrances as a minimum, San Mateo Medical Center demonstrates its forward-thinking and proactive stance in deploying Xtract One’s cutting-edge technology designed to help elevate safety while enhancing the overall individual experience.

    “With violent incidents being five times more frequent in healthcare facilities than in other industries, we recognize the unique challenge hospitals face in ensuring a safe environment,” said Peter Evans, CEO of Xtract One. “Our SmartGateway has shown proven efficacy in on-site, real-world testing and we are confident that its deployment at San Mateo Medical Center will provide enhanced security that identifies potential threats of all kinds, including firearms and edged weapons, and minimizes disruptions to patients, staff, and visitors. We’re looking forward to working with San Mateo Medical Center and to showcasing how well SmartGateway supports healthcare facilities’ needs.”

    “Our goal is to create a safe and welcoming environment for everyone who enters our facility so that we can focus on what truly matters–our patients’ well-being” said Robet Blake, COO of San Mateo Medical Center. “Deploying Xtract One’s technology at our main campus reinforces that commitment. After extensive testing of various systems, we found SmartGateway’s innovative technology to be the most effective for our facility’s needs, allowing us to stay ahead of potential threats in order to maintain a secure and welcoming campus for everyone.”

    SmartGateway’s breakthrough innovation provides fast, discreet, and reliable individual screening, utilizing AI-powered sensors that unobtrusively scan guests for weapons and other prohibited items as they walk through. This technology replaces traditional metal detectors, reducing the need to empty pockets, optimizing patron experience by reducing time spent in security lines, and providing critical security insights to maximize screening outcomes. SmartGateway is designed to enable seamless passage through checkpoints and promote uninterrupted flow of movement.

    To learn more, visit www.xtractone.com.

    About Xtract One
    Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

    About San Mateo Medical Center
    San Mateo Medical Center is a public hospital and clinic system fully accredited by The Joint Commission. We operate outpatient clinics throughout the county and an acute-care hospital in San Mateo. Our mission is to “partner with our community to provide excellent healthcare for patients, including those experiencing social, environmental, or economic challenges.” As part of San Mateo County Health, the medical center serves the healthcare needs of all residents of San Mateo County, with an emphasis on education and prevention.

    About Threat Detection and Security Solutions
    Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

    Forward Looking Statements
    This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

    For further information, please contact:
    Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com   
    Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
    Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

    The MIL Network

  • MIL-OSI: Addressing Surging Demand, Vetty Reports Strong Growth, Strategic Wins and Expanded Integrations in 1H 2025

    Source: GlobeNewswire (MIL-OSI)

    AUSTIN, Texas, June 24, 2025 (GLOBE NEWSWIRE) — Seeing a 22.4 percent increase in revenue year over year, Vetty, the one-stop shop hiring acceleration platform, has continued to build on its momentum in the first half of 2025. On pace to surpass its June goals, the company exceeded monthly targets from January to May, reinforcing Vetty’s value in a rapidly evolving market.

    “2025 is proving to be a defining year for Vetty,” said CEO Jason Putnam. “We’re scaling revenue while transforming our leadership team, operations and partnerships to deliver faster, smarter and more agile solutions to our customers.”

    Market Outlook Drives Demand
    Since January, a degree of caution has dominated workforce decision-making, with employers seeking solutions able to accelerate time-to-hire without compromising compliance or candidate experience. Organizations are looking for cost-effective, risk-averse technologies that can streamline hiring processes by augmenting existing systems. Vetty meets these demands with its easily integrated platform that eliminates manual inefficiencies through high-speed, high-compliance workflows for screening and onboarding.

    In this complex and competitive market, Vetty has differentiated itself through numerous strategic initiatives, including:

    • Team Updates: Vetty has appointed Jason Putnam as CEO and Michelle Meehan as Chief Marketing Officer, with Sumanth Channabasappa in charge of Product and Technology. Jennifer Aichele decided to join the company full-time as Chief Financial Officer after completing a fractional assignment. Gregg Moran has signed on to oversee Partnerships, and Roger Dowie and Katrina Polansky have joined on the sales side. Vikrant Viniak was recently named to the company’s board. These fresh voices have brought considerable expertise to the company, driving significant accomplishments in only a few short months.
    • Deeper Integrations and New Partnerships: In 1H 2025, Vetty established partnerships with Bullhorn and Walton Management, expanded its collaboration with Chattr and started building alliances with key system integrators to strengthen its HR technology ecosystem. At the same time, expanded ATS integrations have enabled faster candidate-to-active workflows, supporting Vetty’s accelerated growth in the enterprise.
    • Relentless Innovation: Along with these integrations, Vetty introduced several key enhancements, notably faster, more customizable health screening orders alongside background checks (a standout capability for the industry); automation to improve turnaround times; enhanced progress monitoring; and improved fraud detection using integrated identity verification offerings, further demonstrating the company’s commitment to compliance and operational excellence.
    • Customer Wins: Vetty signed significant new business relationships across several key verticals, including healthcare and healthcare staffing, traditional staffing and high-volume hiring. Representing the company’s growing footprint and measurable impact are:
      • A major healthcare staffing provider with an optimized onboarding process reduced its time to active positive to under five days.
      • A traditional staffing firm that now manages placements from a single platform can fill roles in under four days.
      • Three elder care, nursing and rehab companies, which collectively manage 100 facilities, have digitized state licensing requirements, transforming a paper-based process into a compliant and automated system.

    Looking Ahead: Forecasting Continued Velocity
    Having achieved substantial milestones in the first half of 2025, Vetty intends to stay on its current course moving into the second half of the year. The company’s plans include continued revenue outperformance, developing additional ATS integrations and partnerships, fostering an enviable company culture and fueling product and customer success. To date, these moves have prompted several enterprise wins and record-high participation in key satisfaction metrics, such as USAT surveys.

    Putnam shared, “Over the last few months, we’ve set a strong foundation for Vetty’s next phase of growth. Moving quickly but thoughtfully, what we’ve created is a testament to what Vetty offers – a modern, proactive and valuable solution that makes it possible to win the hiring game.”

    ABOUT VETTY
    Vetty is a one-stop shop hiring acceleration platform where companies can expeditiously complete their screening, credentialing, hiring and onboarding of prospective candidates. Companies count on Vetty to accelerate the time from offer to active and deliver clearly measurable ROI. Learn more at https://vetty.co.

    The MIL Network

  • MIL-OSI: iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

    Source: GlobeNewswire (MIL-OSI)

    Lead amylin receptor agonist engineered antibody significantly reduced acute food intake in a mouse model of obesity, comparable to the efficacy of a leading amylin peptide agonist

    Findings support the potential of antibody-based agonists to address the growing demand for safer, longer-acting treatments for obesity and cardiometabolic diseases

    Conference call today, June 24 at 8:30 a.m. ET to discuss new pre-clinical data and obesity pipeline

    SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of next-generation antibody therapies, today announced preclinical data in which an engineered amylin receptor agonist antibody reduced acute food intake in a mouse model of obesity by 60% (p<0.05), equivalent to the reduction in food intake from a clinically advanced dual amylin and calcitonin receptor agonist (DACRA) peptide (67%). The effect on food intake was monitored over various time points in this side-by-side study with the amylin agonist iBio discovered and a DACRA peptide. The study marks the third target to emerge from iBio’s partnership with AstralBio.

    The successful iBio-AstralBio collaboration now includes multiple novel engineered antibody agonists with a wide range of profiles targeting the amylin receptor, a heterodimeric G protein-coupled receptor (GPCR).

    “Emerging clinical data suggest selective activation of the amylin receptor—rather than dual agonism of the amylin and calcitonin receptors—can match or even exceed DACRA efficacy, with improved tolerability,” said Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer of iBio. “Our AI-enabled antibody discovery platform allows us to precisely dial in that selectivity and specifically target the amylin receptor and even its subtypes. This new program underscores iBio’s commitment to developing next-generation therapies to address the limitations of current treatments in the fast-growing obesity market.”

    Amylin, or islet amyloid polypeptide (IAPP), is a pancreatic B-cell hormone shown to regulate satiety and delay gastric emptying. When activated through receptor agonism, it enhances meal-ending metabolic signals that prolong the feeling of fullness. Amylin receptors (AMYRs), composed of heterodimeric GPCRs, represent a compelling therapeutic target for obesity and other cardiometabolic diseases. iBio’s approach leverages its proprietary Drug Discovery Platform and advanced AI platform to discover innovative antibodies with exceptional selectivity and potency. This allowed the discovery of molecules capable of agonizing a single AMYR subtype or having balanced agonism at multiple receptors (i.e., DACRA-like agonism profile). This precise and versatile GPCR agonist discovery is thought to allow the identification of a best-in-class therapeutic candidate for an optimal profile of quality weight loss, gastrointestinal tolerability, and lean mass preservation.

    Other amylin analogs currently under clinical development have achieved reduced body weight in obese patients of up to 22.7%1 when used in combination with semaglutide and 11.8%2 as monotherapy. By targeting a different set of signaling pathways, this novel approach holds promise not only for enhancing the weight-loss efficacy seen with GLP-1 receptor agonists but also as a monotherapy option for patients who are intolerant or insufficiently responsive to GLP-1-based interventions.

    References

    1. https://www.hcplive.com/view/cagrisema-achieves-22-7-weight-loss-in-phase-3-redefine-1-trial

    2. https://www.biopharmadive.com/news/novo-nordisk-cagrisema-study-results-diabetes-weight-loss/742008/

    Conference Call Details

    iBio will host a conference call today, June 24, at 8:30 a.m. ET to discuss new pre-clinical data and the Company’s obesity pipeline.

    The webcast of the live call may be accessed on the Investors section of the iBio website at ir.ibioinc.com/news-events/ir-calendar. A replay of the webcast will be available on the iBio website for approximately 60 days following the presentation.

    To join the live call, participants need to access this link for dial-in numbers and a unique participation code.

    About iBio, Inc.

    iBio (Nasdaq: IBIO) is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. Our mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com or follow us on LinkedIn.

    Forward-Looking Statements

    Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the potential of antibody-based agonists to address the growing demand for safer, longer-acting treatments for obesity and cardiometabolic diseases, accelerating the development of novel antibodies for obesity and cardiometabolic diseases in partnership with AstralBio Inc., the positive early results supporting iBio’s approach to antibody-based amylin receptor agonism for the treatment of obesity, iBio’s engineered antibody potentially offering differentiated advantages in dosing and tolerability, developing next-generation therapies to address the limitations of current treatments in the fast-growing obesity market, leveraging iBio’s proprietary Drug Discovery Platform and advanced AI platform to discover innovative antibodies with exceptional selectivity and potency and iBio’s approach targeting the amylin receptor holding promise not only for enhancing the weight-loss efficacy seen with GLP-1 receptor agonists but also as a monotherapy option for patients who are intolerant or insufficiently responsive to GLP-1-based interventions. While iBio believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the ability of amylin receptor to be a successful target for obesity and cardiometabolic diseases; iBio’s ability to obtain regulatory approvals for commercialization of its product candidates, or to comply with ongoing regulatory requirements; regulatory limitations relating to iBio’s ability to promote or commercialize its product candidates for specific indications; acceptance of iBio’s product candidates in the marketplace and the successful development, marketing or sale of products; and whether iBio will incur unforeseen expenses or liabilities or other market factors; and the other factors discussed in iBio’s filings with the SEC including its Annual Report on Form 10-K for the year ended June 30, 2024 and its subsequent filings with the SEC on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and iBio undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

    Corporate Contact:
    iBio, Inc.
    Investor Relations
    ir@ibioinc.com

    Media Contacts:
    Ignacio Guerrero-Ros, Ph.D., or David Schull
    Russo Partners, LLC
    Ignacio.guerrero-ros@russopartnersllc.com
    David.schull@russopartnersllc.com
    (858) 717-2310 or (646) 942-5604

    The MIL Network

  • MIL-OSI: Microchip Enhances TrustMANAGER Platform to Support CRA Compliance and Cybersecurity Regulations

    Source: GlobeNewswire (MIL-OSI)

    CHANDLER, Ariz., June 24, 2025 (GLOBE NEWSWIRE) — International cybersecurity regulations continue to adapt to meet the evolving threat landscape. One major focus is on outdated firmware in IoT devices, which can present significant security vulnerabilities. To address these challenges, Microchip Technology (Nasdaq: MCHP) is enhancing its TrustMANAGER platform to include secure code signing and Firmware Over-the-Air (FOTA) update delivery as well as remote management of firmware images, cryptographic keys and digital certificates. These advancements support compliance with the European Cyber Resilience Act (CRA) which mandates strong cybersecurity measures for digital products sold in the European Union (EU). Aligned with standards like the European Telecommunications Standards Institute (ETSI) EN 303 645 baseline requirements of cybersecurity for consumer IoT and the International Society of Automation (ISA)/International Electrotechnical Commission (IEC) 62443 security of industrial automation and control systems standards, the CRA sets a precedent that is expected to influence regulations worldwide.

    Microchip’s ECC608 TrustMANAGER leverages Kudelski IoT’s keySTREAM™ Software as a Service (SaaS) to deliver a secure authentication Integrated Circuit (IC) that is designed to store, protect and manage cryptographic keys and certificates. With the addition of FOTA services, the platform helps customers securely deploy real-time firmware updates to remotely patch vulnerabilities and comply with cybersecurity regulations.

    “As evolving cybersecurity regulations require connected device manufacturers to prioritize the implementation of mechanisms for secure firmware updates, lifecycle credential management and effective fleet deployment,” said Nuri Dagdeviren, corporate vice president of Microchip’s security products business unit. “The addition of FOTA services to Microchip’s TrustMANAGER platform offers a scalable solution that removes the need for manual, and expensive, static infrastructure security updates. FOTA updates allow customers to save resources while fulfilling compliance requirements and helping to future-proof their products against emerging threats and evolving regulations.”

    Further enhancing cybersecurity compliance, the Microchip WINCS02PC Wi-Fi® network controller module used in the TrustMANAGER development kit is now certified against the Radio Equipment Directive (RED) for secure and reliable cloud connectivity. RED establishes strict standards for radio devices in the EU, focusing on network security, data protection and fraud prevention. Beginning August 1, 2025, all wireless devices sold in the EU market must adhere to RED cybersecurity provisions.

    By incorporating these additional services, TrustMANAGER—governed by keySTREAM—tackles key challenges with IoT security, regulatory compliance, device lifecycle management and fleet management. This solution is designed to serve IoT device manufacturers and industrial automation providers. Visit the website to learn more about Microchip’s Trust Platform.

    Development Tools
    The ECC608 TrustMANAGER is compatible with the MPLAB® X Integrated Development Environment (IDE) and supported by Microchip’s CryptoAuth PRO development board (EV89U05A) and the CryptoAuthLib software library. The Trust Platform Design Suite (TPDS) contains a use case example including onboarding educational steps and a firmware code example to enable the keySTREAM service to AWS® with the ECC608 secure element running on a 32-bit Arm® Cortex®-M4-based PIC32CX SG41MCU and a WINCS02PC Wi-Fi module.  

    Pricing and Availability
    You can purchase directly from Microchip or contact a Microchip sales representative or authorized worldwide distributor.

    Resources
    High-res images available through Flickr or editorial contact (feel free to publish):

    About Microchip Technology:
    Microchip Technology Inc. is a leading provider of smart, connected and secure embedded control and processing solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs which reduce risk while lowering total system cost and time to market. The company’s solutions serve over 100,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com.

    Note: The Microchip name and logo, the Microchip logo and MPLAB are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

    The MIL Network

  • MIL-OSI: Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion

    Source: GlobeNewswire (MIL-OSI)

    • Up to $1.25 billion ($250 million upfront) of synthetic royalty funding and up to $750 million in secured debt
    • Innovative partnership enables Revolution Medicines to retain control over pipeline development and global commercialization of daraxonrasib
    • Highlights Royalty Pharma’s unique ability to provide capital at scale to help leading companies achieve their strategic goals
    • Daraxonrasib, in Phase 3 development for pancreatic cancer and non-small cell lung cancer, would be the first targeted therapy to inhibit all major forms of RAS, one of the most common drivers of human cancers

    NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced a $2 billion funding arrangement with Revolution Medicines, consisting of a synthetic royalty of up to $1.25 billion on daraxonrasib and a senior secured loan of up to $750 million. These funds will support Revolution Medicines’ plans for global development and commercialization of daraxonrasib and its pipeline programs for patients with RAS-addicted cancers.

    “We are excited to announce today a groundbreaking partnership that provides Revolution Medicines with up to $2 billion of long-term capital through a customized funding solution that facilitates the expansive development and global commercialization of its leading RAS(ON) inhibitor portfolio,” said Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma. “This partnership exemplifies a new funding paradigm for highly innovative biotech companies. In contrast to a conventional pharma partnership, this large scale and flexible funding agreement enables Revolution Medicines to retain control of the clinical development of daraxonrasib, as well as the ability to capture significant value creation that would result from the successful clinical development and commercialization of its pipeline.”

    “Today’s announcement represents a major boost to our bold vision on behalf of patients with RAS-addicted cancers,” said Mark A. Goldsmith M.D., Ph.D., Chief Executive Officer and Chairman of Revolution Medicines. “This funding agreement significantly increases the financial resources we can deploy while preserving optionality as we scale our operations to create the industry-leading global targeted medicines franchise for patients with RAS-addicted cancers based on our highly differentiated RAS(ON) inhibitor portfolio.”

    Daraxonrasib, a RAS(ON) multi-selective inhibitor, is a potential practice-changing medicine in Phase 3 development for RAS mutant pancreatic canceri and non-small cell lung cancer (NSCLC). RAS is one of the most commonly mutated genes in human cancer. There are currently no approved targeted therapies that broadly target RAS for these cancers. In the United States, approximately 56,000 patients are diagnosed with RAS-driven pancreatic cancer annually, while approximately 60,000 patients are diagnosed with RAS-driven NSCLC annually. Revolution Medicines expects Phase 3 results for daraxonrasib in pancreatic cancer in 2026 and the Phase 3 NSCLC study is currently enrolling patients.   

    Royalty Terms

    Royalty Pharma will provide up to $1.25 billion in exchange for a synthetic royalty on annual worldwide net sales of daraxonrasib (and zoldonrasib if approved in an overlapping daraxonrasib indication). Details on the terms of the royalty agreement are shown in the table below.

    Royalty terms Tranche 1 Tranche 2 Tranche 3(1) Tranche 4(1) Tranche 5(1) Total
    Amount $250m $250m Up to $250m Up to $250m Up to $250m $1.25 bn
    Timing Immediate Positive data
    (RASolute 302)
    FDA approval in 2L pancreatic cancer Sales milestone achievement Positive Phase 3 data in 1L pancreatic cancer
    Draw Required Required Revolution Medicines option Revolution Medicines option Revolution Medicines option
    Annual sales: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers:
    $0-2 bn
    $2-$4 bn
    $4-$8 bn
    2.55%(2)
    1.50%
    0.60%
    2.00%(2)
    1.00%
    0.40%
    1.50%
    0.80%
    0.40%
    1.00%
    0.75%
    0.50%
    0.75%
    0.50%
    0.50%
    7.80%(2)
    4.55%
    2.40%

    FDA: Food and Drug Administration; 1L: first-line; 2L: second-line
    1 Royalty rates will be adjusted pro-rata depending on draw amount.
    2 The royalty rate on annual sales of $0-2 billion may increase from 2030 to 2041 in the event that sales in the immediate prior year are below an agreed-upon threshold

    Term Loan

    Royalty Pharma will provide a senior secured term loan of up to $750 million at SOFR plus 5.75% (3.5% SOFR floor) which matures six years after the first tranche of $250 million is drawn. The first tranche must be drawn following U.S. Food and Drug Administration approval of daraxonrasib for metastatic pancreatic cancer. The two additional $250 million tranches are available at Revolution Medicines’ option based on the achievement of certain annual net sales milestones for daraxonrasib. Royalty Pharma retains the flexibility to syndicate all or a portion of this loan with other investors.

    Advisors

    Goodwin Procter and Maiwald acted as legal advisors to Royalty Pharma. Latham & Watkins acted as legal advisor and TD Securities acted as financial advisor to Revolution Medicines.

    About Royalty Pharma

    Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates.

    Forward-Looking Statements

    The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this document unless stated otherwise, and neither the delivery of this document at any time, nor any sale of securities, shall under any circumstances create an implication that the information contained herein is correct as of any time after such date or that information will be updated or revised to reflect information that subsequently becomes available or changes occurring after the date hereof. This document contains statements that constitute “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995, including statements that express the company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results, in contrast with statements that reflect historical facts. Examples include discussion of Royalty Pharma’s strategies, financing plans, growth opportunities, market growth, and plans for capital deployment. In some cases, you can identify such forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “target,” “forecast,” “guidance,” “goal,” “predicts,” “project,” “potential” or “continue,” the negative of these terms or similar expressions. Forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to the company. However, these forward-looking statements are not a guarantee of Royalty Pharma’s performance, and you should not place undue reliance on such statements. Forward-looking statements are subject to many risks, uncertainties and other variable circumstances, and other factors. Such risks and uncertainties may cause the statements to be inaccurate and readers are cautioned not to place undue reliance on such statements. Many of these risks are outside of Royalty Pharma’s control and could cause its actual results to differ materially from those it thought would occur. The forward-looking statements included in this document are made only as of the date hereof. Royalty Pharma does not undertake, and specifically declines, any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments, except as required by law. For further information, please reference Royalty Pharma’s reports and documents filed with the U.S. Securities and Exchange Commission (“SEC”) by visiting EDGAR on the SEC’s website at www.sec.gov.

    Royalty Pharma Investor Relations and Communications

    +1 (212) 883-6637
    ir@royaltypharma.com

    _______________________
    i Pancreatic adenocarcinoma (PDAC)

    The MIL Network

  • MIL-OSI: Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities

    Source: GlobeNewswire (MIL-OSI)

    OTTAWA, Ontario, June 24, 2025 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and strategic growth critical infrastructure sectors, today announced that Chris Pogue will join the company as President, Defence & Space, effective July 7, 2025. In this newly created role, Pogue will lead a high-performance organization that brings together Calian’s Advanced Technologies and Learning business units—leveraging the synergies of its communications and manufacturing solutions alongside its immersive training and simulation expertise to accelerate mission success for defence and space customers alike.

    “Chris Pogue is one of Canada’s most accomplished leaders in defence and space innovation,” said Kevin Ford, CEO of Calian. “His track record—growing Thales Canada’s support of the Canadian Armed Forces, leading MDA Government’s Radarsat Constellation mission and building global simulation-based services—gives him the vision and operational rigor to power Calian’s next-generation  defence & space capabilities.”

    Pogue brings over 20 years of senior executive experience. He most recently served as President and CEO of Thales Canada, where he expanded naval support services, re-established land-forces capabilities, and guided key AI and digital transformation initiatives. Prior to Thales, he led MDA Government’s Defence Space portfolio and held leadership roles at General Dynamics Mission Systems Canada and CAE Professional Services. Throughout his career, Pogue has championed the development of innovation ecosystems by connecting Canadian small and medium-sized businesses to national defence and space priorities. A retired Royal Canadian Air Force officer with more than 3,500 flight hours on the C-130 Hercules.

    “I’m thrilled to join Calian at such a pivotal time—for the company, and for Canada and its allies—as we face increasingly complex global uncertainty and opportunities,” said Pogue. “Bringing together the subject matter experts and leading-edge solutions from Advanced Technologies and Learning allows us to harness our collective strengths, co-innovate with our space and defence partners, and deliver the reliability and precision mission success demands.”

    This appointment supports the company’s One Calian 2026 strategy—strengthening its ability to deliver mission critical solutions when failure is not an option. It reinforces Calian’s commitment to innovation, customer success and operational excellence as it scales to meet growing global demand.

    About Calian

    www.calian.com

    We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex challenges. That’s Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.

    Product or service names mentioned herein may be the trademarks of their respective owners.

    Media inquiries:

    media@calian.com

    613-599-8600

    Investor Relations inquiries:

    ir@calian.com

    DISCLAIMER

    Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

    Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
    Tel: 613.599.8600 · Fax: 613-592-3664 · General info email:
    info@calian.com

    The MIL Network

  • MIL-OSI: Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities

    Source: GlobeNewswire (MIL-OSI)

    OTTAWA, Ontario, June 24, 2025 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and strategic growth critical infrastructure sectors, today announced that Chris Pogue will join the company as President, Defence & Space, effective July 7, 2025. In this newly created role, Pogue will lead a high-performance organization that brings together Calian’s Advanced Technologies and Learning business units—leveraging the synergies of its communications and manufacturing solutions alongside its immersive training and simulation expertise to accelerate mission success for defence and space customers alike.

    “Chris Pogue is one of Canada’s most accomplished leaders in defence and space innovation,” said Kevin Ford, CEO of Calian. “His track record—growing Thales Canada’s support of the Canadian Armed Forces, leading MDA Government’s Radarsat Constellation mission and building global simulation-based services—gives him the vision and operational rigor to power Calian’s next-generation  defence & space capabilities.”

    Pogue brings over 20 years of senior executive experience. He most recently served as President and CEO of Thales Canada, where he expanded naval support services, re-established land-forces capabilities, and guided key AI and digital transformation initiatives. Prior to Thales, he led MDA Government’s Defence Space portfolio and held leadership roles at General Dynamics Mission Systems Canada and CAE Professional Services. Throughout his career, Pogue has championed the development of innovation ecosystems by connecting Canadian small and medium-sized businesses to national defence and space priorities. A retired Royal Canadian Air Force officer with more than 3,500 flight hours on the C-130 Hercules.

    “I’m thrilled to join Calian at such a pivotal time—for the company, and for Canada and its allies—as we face increasingly complex global uncertainty and opportunities,” said Pogue. “Bringing together the subject matter experts and leading-edge solutions from Advanced Technologies and Learning allows us to harness our collective strengths, co-innovate with our space and defence partners, and deliver the reliability and precision mission success demands.”

    This appointment supports the company’s One Calian 2026 strategy—strengthening its ability to deliver mission critical solutions when failure is not an option. It reinforces Calian’s commitment to innovation, customer success and operational excellence as it scales to meet growing global demand.

    About Calian

    www.calian.com

    We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex challenges. That’s Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.

    Product or service names mentioned herein may be the trademarks of their respective owners.

    Media inquiries:

    media@calian.com

    613-599-8600

    Investor Relations inquiries:

    ir@calian.com

    DISCLAIMER

    Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

    Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
    Tel: 613.599.8600 · Fax: 613-592-3664 · General info email:
    info@calian.com

    The MIL Network

  • MIL-OSI: Array Technologies Announces Proposed Private Offering of $250 Million of New Convertible Senior Notes

    Source: GlobeNewswire (MIL-OSI)

    ALBUQUERQUE, N.M., June 24, 2025 (GLOBE NEWSWIRE) — Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “ARRAY”) today announced that, subject to market conditions, it intends to offer $250 million in aggregate principal amount of convertible senior notes due 2031 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). ARRAY also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period from, and including the date on which the Notes are first issued, up to an additional $37.5 million aggregate principal amount of Notes.

    The Notes will be senior, unsecured obligations of ARRAY, and will accrue interest payable semiannually in arrears. ARRAY will settle conversions by paying cash up to the aggregate principal amount of the Notes to be converted and paying or delivering, as the case may be, cash, shares of ARRAY’s common stock or a combination of cash and shares of ARRAY’s common stock, at ARRAY’s election, in respect of the remainder, if any, of ARRAY’s conversion obligation in excess of the aggregate principal amount of the Notes being converted, based on the then applicable conversion rate.

    The interest rate, the initial conversion rate and certain other terms of the Notes will be determined at the time of pricing of the Offering.

    ARRAY intends to use the net proceeds from the Offering (i) to repay $150 million of the outstanding indebtedness under its term loan facility, (ii) to fund the costs of the capped call transactions described below and (iii) the remainder, if any, for general corporate purposes, which may include additional repayments or repurchases of outstanding indebtedness, including any repurchases of the Existing Convertible Notes (as defined below). If the initial purchasers exercise their option to purchase additional Notes, ARRAY expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions.    

    In connection with the pricing of the Notes, ARRAY expects to enter into privately negotiated capped call transactions with one or more of the initial purchasers of the Notes or their respective affiliates and/or other financial institutions (the “option counterparties”). The capped call transactions will cover, subject to anti-dilution adjustments, the number of shares of ARRAY’s common stock initially underlying the Notes sold in the Offering. The capped call transactions are expected generally to reduce potential dilution to ARRAY’s common stock upon conversion of any Notes and/or offset any cash payments ARRAY is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.

    ARRAY has been advised that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to purchase shares of ARRAY’s common stock and/or enter into various derivative transactions with respect to ARRAY’s common stock concurrently with or shortly after the pricing of the Notes. This activity could increase (or reduce the size of any decrease in) the market price of ARRAY’s common stock or the Notes at that time. In addition, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to ARRAY’s common stock and/or purchasing or selling ARRAY’s common stock or other securities of ARRAY in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so (x) during any observation period related to a conversion of Notes or following any repurchase of Notes in connection with any “fundamental change” (as defined in the indenture for the Notes) and (y) following any other repurchase of Notes if ARRAY elects to unwind a portion of the capped call transactions in connection with such repurchase). This activity could also cause or avoid an increase or decrease in the market price of ARRAY’s common stock or the Notes, which could affect the ability of noteholders to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, it could affect the amount and value of the consideration that noteholders will receive upon conversion of the Notes.

    In connection with the pricing of the Notes, ARRAY may enter into one or more separate and individually negotiated transactions with one or more holders of ARRAY’s 1.00% Convertible Senior Notes due 2028 (the “Existing Convertible Notes”) to repurchase for cash a portion of the outstanding Existing Convertible Notes, on terms to be negotiated with each holder, using a portion of the net proceeds from the Offering. No assurance can be given as to how much, if any, of the Existing Convertible Notes will be repurchased or the terms on which they will be repurchased. Holders of any Existing Convertible Notes that are repurchased as described above may enter into or unwind various derivatives with respect to ARRAY’s common stock (including entering into derivatives with one or more of the initial purchasers in the Offering or their respective affiliates) and/or purchase or sell shares of ARRAY’s common stock, which may occur concurrently with or shortly after the pricing of the Notes.

    Neither the Notes nor the shares of ARRAY’s common stock potentially issuable upon conversion of the Notes, if any, have been, or will be, registered under the Securities Act, the securities laws of any other jurisdiction or any state securities laws and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. The Notes will be offered and sold only to persons reasonably believed to be qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act. This news release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such offer, solicitation or sale is unlawful. No assurance can be made that the Offering will be consummated on its proposed terms or at all.

    About Array Technologies, Inc.

    ARRAY Technologies, Inc. (NASDAQ: ARRY) is a leading global provider of solar tracking technology to utility-scale and distributed generation customers, who construct, develop, and operate solar PV sites. With solutions engineered to withstand the harshest weather conditions, ARRAY’s high-quality solar trackers, software platforms and field services combine to maximize energy production and deliver value to ARRAY’s customers for the entire lifecycle of a project. Founded and headquartered in the United States, ARRAY is rooted in manufacturing and driven by technology – relying on its domestic manufacturing, diversified global supply chain, and customer-centric approach to design, deliver, commission, train, and support solar energy deployment around the world.

    Media Contact:
    Nicole Stewart
    505-589-8257
    nicole.stewart@arraytechinc.com

    Investor Relations Contact:
    ARRAY Technologies, Inc.

    Investor Relations
    investors@arraytechinc.com

    Forward-Looking Statements

    This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “shall,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the anticipated terms of the Notes, the completion, timing and size of the Offering and capped call transactions, the anticipated effects of entering into the capped call transactions, and the intended use of the net proceeds from the Offering, any Existing Convertible Notes repurchases and the anticipated effects thereof. Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond the Company’s control) that could cause actual results to differ materially from those set forth in the forward looking statements, including risks and uncertainties associated with market conditions, including market interest rates, the trading price and volatility of ARRAY’s common stock, and risks relating to this Offering, the Company’s business and operations and results of financing efforts, including those described in more detail in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 and subsequent reports and other documents on file with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release speak only as of the date of this press release. Except as required by law, the Company does not undertake, and specifically disclaims, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

    The MIL Network

  • MIL-OSI: BloFin futures performance rivals top exchanges across BTC, ETH, and leading altcoins

    Source: GlobeNewswire (MIL-OSI)

    ROAD TOWN, Virgin Islands, June 24, 2025 (GLOBE NEWSWIRE) — BloFin strengthens its position as a global leader in futures trading liquidity and slippage control, outperforming mid-tier competitors and matching the performance of top-tier exchanges.

    BloFin Exchange has achieved a significant milestone in future market performance, establishing itself as a top-tier competitor in both liquidity and trade execution quality. According to the latest official data collected via API monitoring from June 16 to June 19, 2025, BloFin’s futures market depth and slippage performance position the exchange alongside long-established industry leaders such as Binance, OKX, and Bybit, further solidifying its reputation among global futures market participants.

    Tier-1 futures liquidity achieved, with a top-two global ranking across depth metrics

    In cumulative futures depth at both the 0.1% and 0.05% price deviation levels, BloFin ranked firmly among the top three global exchanges. Its liquidity performance not only outpaced all mid-tier platforms but also closely matched or exceeded several tier-1 competitors.

    • At the 0.1% depth level, BloFin secured the second position in overall futures liquidity with a total cumulative depth of 92.6 million, surpassing OKX and coming in just behind Binance.
    • At the 0.05% depth level, BloFin maintained a strong second-place ranking with a cumulative depth of 46.1 million, outperforming both OKX and Binance under tighter market conditions.

    These results demonstrate BloFin’s consistent capacity to support high-volume, low-slippage trading activity for institutional participants and large-volume retail users.

    Whale-grade slippage control delivers execution quality on par with leading exchanges

    In addition to liquidity depth, BloFin exhibited robust trade execution metrics under stress-tested conditions. The exchange delivered highly competitive slippage rates for both BTC and ETH futures, alongside a wide range of over 15 actively traded altcoins, including SOL, XRP, DOGE, PEPE, ADA, and TRUMP.

    BloFin’s slippage performance for major assets under two levels of simulated stress remained in line with top-tier platforms, confirming the exchange’s ability to maintain price stability and execution efficiency in volatile or high-demand trading environments. Notably, BloFin also offered lower slippages for trending, volatile altcoins — an area where many mid-tier competitors face significant execution gaps.

    A new global contender reshaping the futures trading landscape

    BloFin’s performance in this report affirms its standing as a rising leader in the global futures market. By delivering futures market depth and slippage control on par with tier-1 exchanges, BloFin strengthens its appeal to whales, institutional traders, and high-frequency participants seeking deep liquidity and reliable trade execution across both dominant and emerging digital assets.

    As the exchange continues its expansion into key global markets and strategic event sponsorships, this achievement further enhances BloFin’s credibility as a serious futures market contender.

    About BloFin

    BloFin is a top-tier cryptocurrency exchange that specializes in futures trading. The platform offers 480+ USDT-M perpetual pairs, Coin-Margined Perpetual Contracts, spot trading, copy trading, API access, unified account management, and advanced sub-account solutions. Committed to security and compliance, BloFin integrates Fireblocks and Chainalysis to ensure robust asset protection. By partnering with top affiliates, BloFin delivers scalable trading solutions, efficient fund management, and enhanced flexibility for professional traders. As the constant sponsor of TOKEN2049, BloFin continues to expand its global presence, reinforcing its position as the place “WHERE WHALES ARE MADE.” For more information, visit BloFin’s official website at https://www.blofin.com.

    Contact:

    Annio W.
    annio@blofin.io

    Disclaimer: This is a paid post and is provided by Blofin. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ed503f50-4ab2-41f1-95cc-7e54a90942aa

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f1d05780-6070-4dad-b940-987dc2f69334

    https://www.globenewswire.com/NewsRoom/AttachmentNg/6e7cd7e1-174f-4e74-be9c-8b38f4acad05

    The MIL Network

  • MIL-OSI: BloFin futures performance rivals top exchanges across BTC, ETH, and leading altcoins

    Source: GlobeNewswire (MIL-OSI)

    ROAD TOWN, Virgin Islands, June 24, 2025 (GLOBE NEWSWIRE) — BloFin strengthens its position as a global leader in futures trading liquidity and slippage control, outperforming mid-tier competitors and matching the performance of top-tier exchanges.

    BloFin Exchange has achieved a significant milestone in future market performance, establishing itself as a top-tier competitor in both liquidity and trade execution quality. According to the latest official data collected via API monitoring from June 16 to June 19, 2025, BloFin’s futures market depth and slippage performance position the exchange alongside long-established industry leaders such as Binance, OKX, and Bybit, further solidifying its reputation among global futures market participants.

    Tier-1 futures liquidity achieved, with a top-two global ranking across depth metrics

    In cumulative futures depth at both the 0.1% and 0.05% price deviation levels, BloFin ranked firmly among the top three global exchanges. Its liquidity performance not only outpaced all mid-tier platforms but also closely matched or exceeded several tier-1 competitors.

    • At the 0.1% depth level, BloFin secured the second position in overall futures liquidity with a total cumulative depth of 92.6 million, surpassing OKX and coming in just behind Binance.
    • At the 0.05% depth level, BloFin maintained a strong second-place ranking with a cumulative depth of 46.1 million, outperforming both OKX and Binance under tighter market conditions.

    These results demonstrate BloFin’s consistent capacity to support high-volume, low-slippage trading activity for institutional participants and large-volume retail users.

    Whale-grade slippage control delivers execution quality on par with leading exchanges

    In addition to liquidity depth, BloFin exhibited robust trade execution metrics under stress-tested conditions. The exchange delivered highly competitive slippage rates for both BTC and ETH futures, alongside a wide range of over 15 actively traded altcoins, including SOL, XRP, DOGE, PEPE, ADA, and TRUMP.

    BloFin’s slippage performance for major assets under two levels of simulated stress remained in line with top-tier platforms, confirming the exchange’s ability to maintain price stability and execution efficiency in volatile or high-demand trading environments. Notably, BloFin also offered lower slippages for trending, volatile altcoins — an area where many mid-tier competitors face significant execution gaps.

    A new global contender reshaping the futures trading landscape

    BloFin’s performance in this report affirms its standing as a rising leader in the global futures market. By delivering futures market depth and slippage control on par with tier-1 exchanges, BloFin strengthens its appeal to whales, institutional traders, and high-frequency participants seeking deep liquidity and reliable trade execution across both dominant and emerging digital assets.

    As the exchange continues its expansion into key global markets and strategic event sponsorships, this achievement further enhances BloFin’s credibility as a serious futures market contender.

    About BloFin

    BloFin is a top-tier cryptocurrency exchange that specializes in futures trading. The platform offers 480+ USDT-M perpetual pairs, Coin-Margined Perpetual Contracts, spot trading, copy trading, API access, unified account management, and advanced sub-account solutions. Committed to security and compliance, BloFin integrates Fireblocks and Chainalysis to ensure robust asset protection. By partnering with top affiliates, BloFin delivers scalable trading solutions, efficient fund management, and enhanced flexibility for professional traders. As the constant sponsor of TOKEN2049, BloFin continues to expand its global presence, reinforcing its position as the place “WHERE WHALES ARE MADE.” For more information, visit BloFin’s official website at https://www.blofin.com.

    Contact:

    Annio W.
    annio@blofin.io

    Disclaimer: This is a paid post and is provided by Blofin. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ed503f50-4ab2-41f1-95cc-7e54a90942aa

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f1d05780-6070-4dad-b940-987dc2f69334

    https://www.globenewswire.com/NewsRoom/AttachmentNg/6e7cd7e1-174f-4e74-be9c-8b38f4acad05

    The MIL Network

  • MIL-OSI: KIF18A Inhibitor Clinical Trials FDA Approved KIF18A Targeting Therapies Market Report

    Source: GlobeNewswire (MIL-OSI)

    Delhi, June 24, 2025 (GLOBE NEWSWIRE) — Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 Report Highlights & Findings:

    • First KIF18A Targeting Therapy Commercial Availability Expected By 2030
    • Highest Phase Of Development: Phase-I/II
    • KIF18A Targeting Therapies In Clinical Trials:  > 10 Therapies
    • KIF18A Targeting Therapies Clinical Trials Insight By Company, Country, Indication & Phase
    • KIF18A Targeting Therapies Market Development Trends Insight
    • KIF18A Therapies Technology Platforms Insight

    Download Report: https://www.kuickresearch.com/report-kif18a-targeting-inhibitor-kif18a-inhibitor-clinical-trials-kif18a-targeting-therapy

    The global oncology landscape is witnessing rapid progress in precision medicine, and one of the most lead nominees in emerging targets is Kinesin Family Member 18A (KIF18A). It is a mitotic motor protein that is essential for chromosome alignment during mitosis, which facilitates proper segregation of chromosomes. Its perturbation leads to genomic instability, which is a distinguishing feature of cancer. Extrapolations of KIF18A have also been seen in various cancers such as ovarian and breast cancer, with an association with prognosis, drug resistance, and the potential to metastasize. As a crucial protein involved in mitosis and overexpression in cancer, KIF18A is now a promising therapeutic target.

    Targeting KIF18A interferes with mitotic mechanisms in chromosomally unstable (CIN-positive) cancer cells, causing selective death of cancer cells. In contrast to conventional chemotherapies, which indiscriminately impact all proliferating cells, KIF18A inhibitors provide a more selective and less toxic option by taking advantage of cancer cells’ vulnerability to proper mitosis. The major approach is small molecule inhibitors that disrupt KIF18A’s motor activity, hindering it from modulating microtubule dynamics at the kinetochore. It leads to mitotic arrest and failure of chromosome alignment, ultimately triggering apoptosis in cancer cells.

    Clinical development is progressing well. Volastra Therapeutics, a forerunner in this arena, is developing two KIF18A-targeting molecules: Sovilnesib (AMG650), acquired from Amgen and underway in Phase I trials for platinum-resistant high-grade serous ovarian cancer, and VLS-1488, an in-house oral inhibitor in Phase I/II. Both molecules displayed favorable safety profiles and early anti-tumor effects, with particular efficacy in high-chromosomal-instability tumors. Volastra’s pipeline demonstrates the therapeutic potential of inhibiting KIF18A to treat difficult-to-treat cancers.

    Accent Therapeutics is also advancing with ATX-295, an oral KIF18A inhibitor in initial clinical testing for solid tumors such as triple-negative breast and high-grade serous ovarian cancers. Their biomarker strategy makes use of genomic instability markers such as whole-genome doubling to better optimize patient selection and optimize therapy outcomes.

    AI based drug discovery is providing additional impetus to this area. Insilico Medicine has utilized proprietary platforms such as Chemistry42 and PandaOmics to discover ISM9682, a new macrocyclic KIF18A inhibitor with high preclinical efficacy. The AI platforms facilitate rapid optimization of candidates with increased specificity and pharmacological profiles, highlighting the growing use of sophisticated computational approaches in drug discovery.

    Aside from clinical advancement, the market opportunity for KIF18A inhibitors is also robust. As precision oncology gains more attention, the therapies are well poised to capture the opportunity of targeted therapies, particularly in diseases that are refractory to current treatments. Various companies, including Nvidia-funded Iambic Therapeutics, Aurigene Oncology, Simcere Zaiming Pharmaceutical, and Amgen, are developing promising product candidates in preclinical phases.

    Overall, the KIF18A-targeted therapy market is changing very quickly, powered by strong scientific justification, initial clinical success, and novel development approaches. As additional preclinical and clinical information becomes available, the market has significant potential for strong growth, powered by partnerships, application of artificial intelligence and machine learning tactics, and the overall dedication to creating targeted and individualized cancer therapeutics.

    The MIL Network

  • MIL-OSI: Walking Comfort Accelerates Ecommerce Growth with Descartes Sellercloud™

    Source: GlobeNewswire (MIL-OSI)

    ATLANTA, June 24, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Utah-based Walking Comfort, a leading retailer in the local and online footwear market, is using Descartes Sellercloud™ to help drive ecommerce growth by centralizing and synchronizing the management of product listings, inventory, orders and fulfillment across multiple online sales channels.

    “As the business grew and we expanded to a larger warehouse and more online marketplaces, we realized we needed a more sophisticated inventory and order management system to boost time-savings and operating efficiencies,” said Brad Hendricksen, Accounting and Operations Manager at Walking Comfort. “With Descartes Sellercloud, we have a powerful platform that has facilitated ecommerce growth, saved us hundreds of hours per week by automatically consolidating data across all sales channels, eliminated picking errors so staff no longer pick the wrong size or variation, and cut shipping costs by more than 55%—even enabling us to dropship directly from retail locations if it’s the most convenient and cost-effective option for a customer.”

    Descartes Sellercloud is a cloud-based ecommerce platform that helps small and mid-market retailers, distributors, wholesalers, and manufacturers with omnichannel ecommerce operations centralize the management of their catalog, inventory, orders, purchasing, fulfillment and shipping. With 350+ integrations, including to marketplaces, shopping carts, shipping partners, third party logistics providers, payment gateways and vendors, the solution provides a comprehensive ecommerce ecosystem that companies can easily leverage to expand operations as they grow.

    “We’re pleased our solution is supporting Walking Comfort as they’ve grown their business,” said Mikel Richardson, General Manager, Ecommerce at Descartes. “Using the platform, sellers can reduce operational complexity by simultaneously updating inventory and orders in real-time, avoid underselling and overselling inventory, stay compliant with marketplaces requirements, save shipping costs by automating fulfillment, and grow their business by adding more sales channels and products without losing control of inventory or order visibility.”

    Learn more about Descartes Sellercloud and Descartes’ Ecommerce Shipping and Fulfillment solutions.

    About Walking Comfort

    Walking Comfort sells various footwear products, including running shoes, slippers, sandals, recovery footwear, and accessories like insoles. Founded in 2008, they are based in Centerville, Utah, and have 35 employees and two brick-and-mortar locations. For more information, visit www.walkingcomfort.com.

    About Descartes

    Descartes (Nasdaq:DSGX) (TSX:DSG) is the global leader in providing on-demand, software-as-a-service solutions focused on improving the productivity, security and sustainability of logistics-intensive businesses. Customers use our modular, software-as-a-service solutions to route, track and help improve the safety, performance and compliance of delivery resources; plan, allocate and execute shipments; rate, audit and pay transportation invoices; access global trade data; file customs and security documents for imports and exports; and complete numerous other logistics processes by participating in the world’s largest, collaborative multimodal logistics community. Our headquarters are in Waterloo, Ontario, Canada and we have offices and partners around the world. Learn more at www.descartes.com, and connect with us on LinkedIn and Twitter.

    Global Media Contact
    Cara Strohack
    Tel: 226-750-8050
    cstrohack@descartes.com

    Cautionary Statement Regarding Forward-Looking Statements

    This release contains forward-looking information within the meaning of applicable securities laws (“forward-looking statements”) that relate to Descartes’ ecommerce solution offerings and potential benefits derived therefrom; and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, “Certain Factors That May Affect Future Results” in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities commissions across Canada including Descartes’ most recently filed management’s discussion and analysis. If any such risks actually occur, they could materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

    The MIL Network

  • MIL-OSI: Castellum, Inc. Announces Creation of New Subsidiary to Focus on Advanced Technology Products

    Source: GlobeNewswire (MIL-OSI)

    VIENNA, Va., June 24, 2025 (GLOBE NEWSWIRE) — Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services and solutions company focused on the federal government, today announced the creation of a new wholly owned subsidiary, Castellum Advanced Technology Products, Inc. (“CATP”).

    CATP will focus on teaming with other leading-edge technology companies, developing technology internally, and potentially taking equity positions in companies that have advanced technology, which Castellum’s Department of Defense customers could use.

    “Fully and timely leveraging advanced technology is the key to success on the 21st-century battlefield,” said Glen Ives, Chief Executive Officer of Castellum. “While we will continue to provide technology-enabled services to our government clients, today’s announcement represents a meaningful broadening of Castellum’s strategy for supporting the Department of Defense. We believe that having greater control over some of the key products our customers need will enable us to provide better overall solutions for the warfighter. Financially, we believe that we can increase both our revenue and our operating margins by adding more value and solving our customers’ most challenging problems. This important step reinforces our priority, focus, and commitment to constantly strengthen and enhance our organic growth capabilities.”

    About Castellum, Inc. (NYSE-American: CTM):

    Castellum, Inc. (NYSE-American: CTM) is a cybersecurity, electronic warfare, and software engineering services company focused on the federal government – https://castellumus.com/.

    Forward-Looking Statements:

    This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Words such as “will,” “would,” “believe,” and “expects,” and similar language or phrasing are indicative of forward-looking statements. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company’s control, that could cause actual results to differ (sometimes materially) from the results expressed or implied in the forward-looking statements, including, among others: the Company’s ability to effectively integrate and grow its acquired companies; its ability to identify additional acquisition targets and close additional acquisitions; the impact on the Company’s revenue due to a delay in the U.S. Congress approving a federal budget, operating under a prolonged continuing resolution, government shutdown, or breach of the debt ceiling, as well as the imposition by the U.S. government of sequestration in the absence of an approved budget; the ability of the U.S. federal government to unilaterally cancel a contract with or without cause, and more specifically, the potential impact of the U.S. DOGE Service Temporary Organization on government spending and terminating contracts for convenience. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in Item 1A. “Risk Factors” section of the Company’s recently filed Form 10-Q, Item 1A. “Risk Factors” in the Company’s most recent Form 10-K, and other filings with the Securities and Exchange Commission which can be viewed at www.sec.gov. These risks and uncertainties, or not closing the described potential equity financing in this press release, could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

    Contact:

    Glen Ives
    President and Chief Executive Officer
    Phone: (703) 752-6157
    info@castellumus.com
    https://castellumus.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/12cff6dc-d18b-4810-9020-5e7bab268788

    The MIL Network

  • MIL-OSI: RentRedi Survey: Smaller Landlords 60% More Likely to Enforce Renters Insurance

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) — A new joint survey from RentRedi, the fastest-growing landlord software that makes renting easy for everyone, and BiggerPockets, the largest online community for real estate investors, reveals that while most landlords understand the difference between renters insurance and landlord insurance, many still don’t require it—and even fewer take steps to verify it. These results, together with a companion survey conducted by RentRedi alone, highlight that many real estate investors are still exploring the best ways to implement and manage renters insurance within their rental process.

    The joint survey with BiggerPockets, conducted from June 11–16, 2025, gathered responses from 812 real estate investors and property owners. When asked how they verify renters insurance coverage, half of respondents reported that they currently do not verify whether their tenants have renters insurance. The rest rely on a mix of manual checks, insurance company confirmations, or property management software, demonstrating that many landlords are still exploring the best ways to integrate renters insurance into their rental process.

    This snapshot complements a broader RentRedi survey conducted from March 30 to April 14, 2025 with 1,623 respondents that analyzes landlord behavior across portfolio sizes. The data shows that more than three-fourths of landlords understand the difference between landlord and renters insurance. However, only about one in five landlords offer renters insurance options directly to tenants, and fewer than half include renters insurance as a requirement in the lease.

    Verification and enforcement also vary widely. Roughly four in ten landlords said they follow up to confirm tenants have active coverage, and among those who include a requirement in the lease, the majority—nearly three out of four—said they enforce it. These numbers reflect a growing interest in formalizing and standardizing renters insurance policies as landlords seek to reduce risk and increase protection for both themselves and their tenants.

    Interestingly, landlords with smaller portfolios (1–4 units) were more likely to require and enforce renters insurance. Nearly six in ten small landlords said they include renters insurance in the lease, and four out of five of those said they enforce that requirement. While larger portfolio landlords (20+ units) were less likely to include or enforce these requirements by 22 and 15 point margins respectively, they may benefit most from automation and integrated software solutions to help manage renters insurance at scale.

    “Renters insurance protects everyone involved. It minimizes financial risk, reduces liability, and gives both landlords and tenants greater peace of mind,” said RentRedi Co-founder and CEO Ryan Barone. “These results show that landlords recognize the value but often lack a streamlined way to implement it, and that’s exactly the problem that RentRedi solves.”

    With RentRedi, landlords can easily offer renters insurance options during the application and onboarding process, require proof of coverage within the lease, and automatically verify compliance. Tenants can purchase renters insurance directly through RentRedi’s app, or upload proof of an existing policy, and landlords are notified instantly. RentRedi also integrates with select providers to enable real-time tracking and add landlords as additional insured when needed. The result is a simpler, smarter way for landlords to protect their investments, while also delivering a better experience for tenants.

    In both surveys, percentages have been rounded to the nearest whole number. The full survey results can be found here. This report is part of RentRedi’s ongoing initiative to surface real-world insights from landlords and property managers through data, direct surveys, and collaborations with trusted communities like BiggerPockets. For more data insight and survey result reports, visit RentRedi’s Rental Market Insights.

    About RentRedi

    RentRedi offers an award-winning, comprehensive property management platform that simplifies the renting process for landlords and renters by automating and streamlining processes. Investors can quickly grow their rental businesses by using RentRedi’s all-in-one web and mobile app for rent collection, market listings, tenant screening, lease signing, maintenance coordination, and accounting. Tenants enjoy the convenience and benefits of RentRedi’s easy-to-use mobile app that allows them to pay rent, set up auto-pay, build credit by reporting rent payments to all three major credit bureaus, prequalify and sign leases, and submit 24/7 maintenance requests.

    Founded in 2016, RentRedi is VC-backed and a proven leader in the PropTech market. The company ranks No. 180 on the Inc. 5000 list and No. 13 on the Inc. 5000 Regionals list. It was also named an Inc. Power Partner in 2023 and 2024, and to Fast Company’s Next Big Things in Tech list in 2024, as well as HousingWire’s Tech100 list in 2025. To date, RentRedi has more than $28 billion in assets under management with nearly 200,000 landlords and tenants using its platform. The company partners with technology leaders such as Zillow, TransUnion, Experian, Equifax, Realtor.com, Lessen, Thumbtack, Plaid, and Stripe to create the best customer experience possible. For more information visit RentRedi.com.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/3054c495-1990-46b7-b58b-45792a65b570

    https://www.globenewswire.com/NewsRoom/AttachmentNg/148eb0b8-2512-4a3c-82e4-3f6af3bb3394

    The MIL Network

  • MIL-OSI: Stabilization Notice – PRE STAB – Kepler SPA (BIOFARMA)

    Source: GlobeNewswire (MIL-OSI)

    24/06/25

    Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

    KELPER SPA (BIOFARMA)

    Pre-stabilisation Period Announcement

    BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222 hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).

    The securities:1  
    Issuer: KEPLER SPA (BIOFARMA)
    Guarantor (if any): N/A
    Aggregate nominal amount: TBC
    Description: EUR 4.5NC1
    Offer price: TBC
    Other offer terms:  
    Stabilisation:  
    Stabilisation Manager(s) BNP PARIBAS, ING, JEFFRIES, SMBC, IMI-INTESA SANPAOLO, KCM, NATIXIS, NOMURA
    Stabilisation period expected to start on: 24/06/25
    Stabilisation period expected to end no later than: 08/08/25
    Existence, maximum size and conditions of use of over‑allotment facility: The Stabilisation Manager(s) may over‑allot the securities to the extent permitted in accordance with applicable law.
    Stabilisation trading venue: OTC

    In connection with the offer of the above securities, the Stabilisation Manager(s) may over‑allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over‑allotment shall be conducted in accordance with all applicable laws and rules.

    This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

    This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

    In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK or any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK or that Member State in accordance with Regulation (EU) 2017/1129 (the “Prospectus  Regulation”) (or which has been approved by a competent authority in another Member State and notified to the competent authority in the UK or that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in the UK or that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK or that Member State.

    This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. 

    The MIL Network

  • MIL-OSI: Stabilization Notice – PRE STAB – Kepler SPA (BIOFARMA)

    Source: GlobeNewswire (MIL-OSI)

    24/06/25

    Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

    KELPER SPA (BIOFARMA)

    Pre-stabilisation Period Announcement

    BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222 hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).

    The securities:1  
    Issuer: KEPLER SPA (BIOFARMA)
    Guarantor (if any): N/A
    Aggregate nominal amount: TBC
    Description: EUR 4.5NC1
    Offer price: TBC
    Other offer terms:  
    Stabilisation:  
    Stabilisation Manager(s) BNP PARIBAS, ING, JEFFRIES, SMBC, IMI-INTESA SANPAOLO, KCM, NATIXIS, NOMURA
    Stabilisation period expected to start on: 24/06/25
    Stabilisation period expected to end no later than: 08/08/25
    Existence, maximum size and conditions of use of over‑allotment facility: The Stabilisation Manager(s) may over‑allot the securities to the extent permitted in accordance with applicable law.
    Stabilisation trading venue: OTC

    In connection with the offer of the above securities, the Stabilisation Manager(s) may over‑allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over‑allotment shall be conducted in accordance with all applicable laws and rules.

    This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

    This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

    In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK or any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK or that Member State in accordance with Regulation (EU) 2017/1129 (the “Prospectus  Regulation”) (or which has been approved by a competent authority in another Member State and notified to the competent authority in the UK or that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in the UK or that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK or that Member State.

    This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. 

    The MIL Network